rfhg_73923.1

Basic information about the TSS

---

TSS ID: rfhg_73923.1 Species: human Chr: chr5		Start: 149495735 End: 149495752 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC105984:-500 GeneID: 1452 HGNC/MGI_ID: HGNC:2451 UniProt_ID: Nearer transcript ids and distances:

Gene_name: casein kinase 1 alpha 1 Gene_symbol: CSNK1A1 Gene_synonyms: CK1 CK1a CK1alpha CKIa CKIalpha Gene_source: HGNC:2451

TATA-Box annotation

---

Distance to TSS:	54622
Nearest PromoterID:	NM_001271742
Entrez ID:	1452
Nearest Unigene:	Hs.529862
Nearest Refseq:	NM_001892
Nearest Ensembl:	ENSG00000113712
Gene Name:	casein kinase 1 alpha 1
Gene Alias:	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.222222
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CSNK1A1 p2@CSNK1A1 p3@CSNK1A1 p4@CSNK1A1 p7@CSNK1A1 p8@CSNK1A1 p9@CSNK1A1 p10@CSNK1A1
Sample		p1@CSNK1A1	p2@CSNK1A1	p3@CSNK1A1	p4@CSNK1A1	p7@CSNK1A1	p8@CSNK1A1	p9@CSNK1A1	p10@CSNK1A1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	40.13	6.23	0.97	0.39	1.17	0.78	0.97	17.34
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	40.26	6.88	0.20	0.20	0.81	1.01	0.81	15.78
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	43.98	8.87	0.00	0.19	0.39	0.96	0.96	15.82
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	35.34	6.86	0.21	0.62	1.04	0.42	0.62	13.72
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	38.69	4.27	0.45	0.90	0.67	0.45	1.57	12.60
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	34.11	5.23	0.97	0.58	0.78	0.39	0.58	11.24
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	50.77	10.46	1.53	0.65	1.31	1.09	0.65	16.78
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	32.70	5.33	0.97	0.73	0.73	0.73	0.97	12.60
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	38.68	7.27	0.64	0.85	0.43	1.28	2.14	10.47
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	49.27	12.17	0.00	0.58	2.32	1.74	1.16	21.45
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	43.25	14.55	0.00	0.81	1.62	0.81	2.02	18.19
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	51.63	11.38	2.44	1.63	0.81	1.22	2.44	15.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	23.53	3.55	0.81	0.81	0.64	0.00	0.81	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	22.40	3.31	0.45	0.75	0.30	0.00	0.60	7.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.83	2.42	0.88	0.88	0.44	0.22	0.22	6.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.35	3.27	1.26	1.01	0.50	0.00	0.50	7.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.47	2.18	0.44	0.66	0.22	0.22	0.66	7.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.93	2.53	0.00	0.84	0.84	0.84	0.00	9.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.66	4.27	0.53	1.07	0.53	0.00	0.00	8.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.32	2.41	0.45	1.81	0.30	0.15	0.60	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.85	2.00	0.40	1.47	0.53	0.27	0.27	6.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	24.17	3.28	1.21	0.69	0.17	0.17	0.69	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	20.68	3.23	0.78	0.52	0.13	0.00	0.13	4.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	23.30	1.94	0.73	1.21	0.97	0.00	0.00	6.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.09	2.58	1.55	1.03	0.00	0.26	0.26	8.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.89	3.48	0.63	0.63	0.63	0.00	0.00	9.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.88	2.20	0.55	0.55	0.55	0.55	0.00	14.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.69	3.77	0.24	0.47	0.94	0.94	0.47	5.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	24.55	1.62	0.65	0.81	0.16	0.32	0.16	7.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.35	2.71	1.27	0.90	0.36	0.36	0.18	5.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.84	2.93	0.63	1.05	0.00	0.42	0.00	8.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.10	3.91	0.59	0.98	0.78	0.00	0.20	6.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.09	1.69	0.00	0.42	0.00	0.21	0.00	8.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.09	3.46	2.97	1.32	0.16	0.16	0.33	9.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.26	2.99	0.75	0.56	0.75	0.37	0.19	6.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.08	3.45	0.96	0.57	0.77	0.00	0.38	4.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.03	3.47	0.61	0.41	0.41	0.00	0.41	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.34	1.61	0.81	0.60	0.00	0.00	0.00	4.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.99	0.54	2.16	0.00	0.00	0.54	0.00	6.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.93	1.92	0.96	0.48	0.24	0.24	0.24	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.70	1.65	0.47	0.24	0.24	0.24	0.24	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.66	2.49	1.17	0.88	0.00	0.15	0.15	6.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.66	1.27	1.48	0.42	0.42	0.63	0.42	4.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.43	2.27	1.22	0.70	0.35	0.17	0.00	8.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.88	2.61	1.41	0.60	0.00	0.00	0.80	3.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.29	3.26	1.86	0.70	0.23	0.23	0.00	4.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.31	1.20	1.92	0.72	0.00	0.00	0.00	5.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.29	2.68	1.79	0.30	0.00	0.30	0.60	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.00	4.31	0.96	0.48	0.24	0.24	0.00	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	17.39	4.04	0.61	0.00	0.00	0.20	0.20	4.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	20.09	2.87	2.25	0.61	0.20	0.00	0.41	6.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.46	1.33	1.11	1.33	0.44	0.67	0.44	8.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	0.00	0.00	0.00	0.00	0.00	615.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.39	7.10	1.42	1.77	0.71	0.00	0.35	4.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.58	3.31	0.99	1.33	0.33	0.00	0.00	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	29.36	5.03	4.19	2.52	0.00	0.00	0.00	55.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	14.24	1.38	1.38	2.30	0.00	0.46	0.00	11.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.74	2.92	1.30	0.32	0.32	0.65	1.30	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.88	2.25	0.00	0.64	0.64	0.32	0.00	8.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	24.83	1.57	1.57	1.26	0.63	0.00	0.00	16.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	4.23	2.12	2.82	0.71	1.41	0.71	8.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.90	2.24	1.12	0.00	0.56	0.00	0.00	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.11	0.80	1.59	0.80	0.00	0.00	0.00	56.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.71	2.72	1.02	1.70	0.34	0.00	0.00	12.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	3.57	1.95	1.30	0.00	0.32	0.32	8.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.26	2.84	2.48	0.71	0.00	0.00	0.35	8.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	16.16	0.00	0.00	0.00	0.00	420.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	0.00	0.00	0.00	0.00	15.79	0.00	252.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.11	1.95	1.46	1.95	1.46	0.00	0.00	5.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.36	2.48	0.99	0.99	0.50	0.00	0.00	5.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	2.81	0.94	0.47	0.00	0.47	0.00	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	24.18	2.65	1.99	1.66	0.00	0.66	0.00	7.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.65	1.86	1.55	2.17	0.00	0.31	0.00	5.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.43	1.83	2.14	1.83	0.31	0.00	0.00	4.89
Adipocyte - breast, donor1	11376-118A8	45.14	7.60	2.85	1.90	0.00	0.48	0.48	15.68
Adipocyte - breast, donor2	11327-117E4	32.25	6.26	2.57	1.12	0.48	0.64	0.16	17.97
Adipocyte - omental, donor1	11473-119C6	57.76	9.16	7.12	1.40	0.38	1.02	0.76	20.48
Adipocyte - omental, donor2	11474-119C7	26.16	5.23	2.99	1.49	0.00	0.75	0.00	18.69
Adipocyte - omental, donor3	11475-119C8	24.78	5.36	4.35	0.33	0.67	0.33	0.00	11.72
Adipocyte - perirenal, donor1	11476-119C9	21.05	5.74	1.91	0.00	0.64	1.91	0.00	14.67
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	4.40	0.00	1.10	0.00	0.00	0.00	6.60
Adipocyte - subcutaneous, donor2	11336-117F4	28.45	5.42	4.52	2.26	0.45	0.00	0.00	7.23
Adipocyte - subcutaneous, donor3	11408-118E4	35.80	4.87	1.56	0.35	0.17	0.70	0.35	9.56
Adipocyte differentiation, day04, donor1	13019-139D4	46.94	6.45	3.91	2.74	0.20	0.20	0.39	13.10
Adipocyte differentiation, day04, donor2	13022-139D7	19.82	3.09	3.35	2.32	0.26	0.26	0.00	11.07
Adipocyte differentiation, day04, donor3	13025-139E1	30.11	4.18	3.07	1.67	0.28	0.28	0.56	11.71
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	9.40	5.88	2.35	0.00	0.59	0.59	13.52
Adipocyte differentiation, day08, donor1	13020-139D5	43.27	4.75	1.13	0.88	0.24	0.56	0.48	13.27
Adipocyte differentiation, day08, donor2	13023-139D8	20.98	1.29	2.58	1.61	0.32	0.32	0.32	14.52
Adipocyte differentiation, day08, donor3	13026-139E2	29.33	4.27	0.53	0.53	0.53	0.00	0.53	16.00
Adipocyte differentiation, day08, donor4	13029-139E5	22.26	2.78	0.00	0.56	0.00	0.00	0.00	15.58
Adipocyte differentiation, day12, donor1	13021-139D6	32.02	2.50	0.00	0.42	0.42	0.00	0.00	5.82
Adipocyte differentiation, day12, donor2	13024-139D9	28.13	4.02	1.26	0.50	0.50	0.25	0.75	11.30
Adipocyte differentiation, day12, donor3	13027-139E3	19.31	4.25	0.65	0.33	0.00	0.00	0.33	11.78
Adipocyte differentiation, day12, donor4	13030-139E6	22.23	3.96	1.22	0.61	0.00	0.00	0.30	6.39
Alveolar Epithelial Cells, donor1	11510-119G7	20.99	4.64	0.44	0.22	0.00	0.22	0.44	9.72
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	2.15	0.00	0.00	0.00	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	0.00	0.00	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	30.58	5.04	0.18	0.54	0.00	0.72	0.36	9.89
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	3.35	0.00	0.00	0.00	0.00	0.00	11.71
Amniotic Epithelial Cells, donor3	11694-123A2	26.71	6.37	0.41	0.41	0.21	0.41	0.41	5.14
Anulus Pulposus Cell, donor1	11248-116E6	66.25	8.81	2.86	1.14	0.34	0.46	0.46	24.37
Anulus Pulposus Cell, donor2	11463-119B5	43.59	7.10	3.43	2.45	0.49	0.24	0.49	7.10
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	25.16	3.59	2.25	3.59	0.45	0.45	0.45	22.46
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.56	4.78	1.74	0.87	0.00	0.87	0.00	26.92
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	0.00	0.00	4.28	0.00	2.14	0.00	27.82
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.21	4.18	3.29	1.49	0.30	0.00	0.30	16.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	8.85	3.79	2.53	0.00	0.00	0.00	15.18
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	20.46	2.64	1.98	1.32	0.00	1.32	0.00	19.14
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.42	3.25	2.27	0.97	0.00	0.00	0.65	20.79
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	29.13	4.85	1.94	1.94	0.00	0.00	0.00	24.76
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	29.10	5.94	4.16	2.38	0.59	0.59	0.00	23.76
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	28.62	3.77	2.64	2.26	0.00	0.38	0.00	22.60
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.03	5.81	3.63	0.73	0.00	0.00	0.00	15.96
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	1.25	0.00	0.00	1.25	0.00	0.00	25.08
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	40.69	6.42	3.79	2.47	0.00	0.49	0.49	12.85
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	9.55	0.00	1.36	0.00	1.36	0.00	20.47
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	32.87	6.33	4.98	2.26	0.30	0.60	0.30	16.44
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.54	4.29	1.07	0.54	0.00	1.07	0.00	23.04
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	32.50	5.10	3.02	0.57	0.19	0.38	0.57	19.84
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.01	5.88	4.28	1.07	0.80	0.27	0.53	21.92
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	0.98	1.95	0.98	0.98	0.00	0.00	17.56
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	31.02	4.48	3.98	1.49	0.33	0.17	0.17	19.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	4.80	2.40	6.00	1.20	0.00	0.00	31.22
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	10.62	0.00	0.00	0.00	0.00	0.00	17.70
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.99	3.43	4.29	2.06	0.34	0.34	0.51	18.18
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	4.19	0.00	0.00	0.00	37.75
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.76	4.85	0.00	1.46	0.00	0.00	0.00	20.87
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.01	5.69	4.55	3.04	0.38	0.38	0.00	18.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	1.21	3.63	3.63	0.00	0.00	0.00	16.96
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	20.52	5.70	1.71	2.28	0.57	0.00	0.57	31.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	37.41	5.99	2.14	1.92	0.64	0.64	0.21	17.96
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.94	2.58	4.13	1.81	0.00	0.26	0.77	16.78
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	25.81	4.22	2.82	0.94	0.00	0.94	0.47	19.71
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	29.90	4.50	2.89	3.22	0.32	0.00	0.32	25.40
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	2.85	3.57	0.71	0.00	0.00	0.00	24.97
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	3.51	1.75	2.92	0.00	0.00	0.00	18.72
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.89	4.22	4.82	0.60	0.00	0.30	0.00	19.87
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	34.45	1.19	2.38	1.19	1.19	0.00	0.00	27.32
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	31.53	4.07	5.09	1.53	0.51	0.00	0.00	21.87
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.33	3.57	4.33	0.76	0.25	0.00	0.00	19.87
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	22.24	3.18	3.81	0.64	0.00	0.00	0.00	12.07
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.46	4.75	4.75	2.16	0.00	0.43	1.29	25.46
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	28.15	4.87	3.81	1.48	0.42	0.00	0.21	22.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	23.49	2.03	1.74	0.29	0.29	0.00	0.00	24.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	3.78	0.00	0.00	0.00	1.89	0.00	22.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	28.31	4.75	3.22	1.86	0.34	0.51	0.34	18.31
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	4.63	6.95	0.00	0.00	0.00	0.00	18.53
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	6.34	2.11	4.23	0.00	0.00	2.11	25.35
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.88	4.93	2.57	2.14	0.86	0.21	0.21	15.01
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	1.20	4.21	0.60	0.00	0.60	0.60	21.66
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	30.62	4.37	2.19	1.46	0.00	0.00	0.00	23.33
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	31.26	6.21	4.60	2.53	0.00	0.23	0.23	17.47
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10	5.10	2.55	0.00	0.00	0.00	33.15
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	33.30	8.64	4.32	2.29	0.00	0.51	0.25	20.08
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	39.22	7.02	2.89	2.06	0.41	0.21	0.21	19.61
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.54	5.81	3.06	2.75	0.00	0.00	0.61	17.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	26.77	1.91	1.43	2.87	0.00	0.96	0.00	21.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.61	3.55	2.44	1.55	0.22	0.22	0.67	18.18
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	6.10	1.53	3.05	0.00	0.00	0.00	19.84
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.80	4.98	2.77	0.55	0.00	0.00	0.55	26.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	32.57	4.24	3.71	0.79	0.26	0.00	0.26	18.01
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	26.90	2.18	2.54	2.91	0.00	0.00	0.00	18.54
Astrocyte - cerebellum, donor1	11500-119F6	24.81	4.30	1.23	0.25	0.00	0.49	0.98	10.32
Astrocyte - cerebellum, donor2	11580-120F5	15.40	4.45	0.34	0.00	0.00	0.34	0.00	4.28
Astrocyte - cerebellum, donor3	11661-122F5	17.41	3.99	0.42	0.42	0.00	0.21	0.00	5.87
Astrocyte - cerebral cortex, donor1	11235-116D2	50.20	8.71	1.74	1.05	0.35	0.35	0.70	16.03
Astrocyte - cerebral cortex, donor2	11316-117D2	57.27	10.84	4.04	1.13	0.16	0.65	0.81	20.22
Astrocyte - cerebral cortex, donor3	11392-118C6	39.23	8.35	1.49	0.15	0.45	1.79	0.75	10.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	61.82	11.12	0.11	0.11	0.11	0.69	1.15	9.40
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	52.12	10.77	1.00	0.13	0.25	0.38	0.38	9.77
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	50.53	7.85	0.11	0.11	0.11	1.02	0.91	11.49
Basophils, donor1	12241-129G9	49.69	12.03	1.83	2.35	0.26	0.26	0.52	5.49
Basophils, donor2	12242-129H1	65.66	12.99	2.53	3.61	0.00	2.16	0.36	4.69
Basophils, donor3	12243-129H2	55.27	8.82	2.35	2.20	0.15	0.73	0.73	3.38
Bronchial Epithelial Cell, donor1	11511-119G8	43.77	6.90	0.00	0.43	0.22	0.22	0.22	13.58
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	5.03	0.00	0.00	0.00	0.00	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	0.00	0.00	0.00	0.00	0.00	0.00	86.08
Bronchial Epithelial Cell, donor4	11453-119A4	29.50	7.53	0.63	0.00	0.63	0.00	0.63	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	33.06	6.45	0.42	0.42	1.04	0.42	0.21	2.91
Bronchial Epithelial Cell, donor6	11461-119B3	58.95	12.44	0.46	0.23	1.84	0.23	0.23	6.68
Bronchial Epithelial Cell, donor7	11769-123I5	57.76	9.18	0.36	0.36	0.72	0.18	0.54	28.07
Burkitt's lymphoma cell line:DAUDI	10422-106C8	35.24	8.14	0.00	0.00	0.21	1.85	1.55	10.51
Burkitt's lymphoma cell line:RAJI	10476-106I8	41.46	6.99	0.00	0.00	0.23	0.93	1.16	10.01
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	44.45	5.76	1.92	2.24	0.00	1.28	0.00	6.40
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	67.06	12.96	3.94	7.89	0.00	1.13	0.56	16.91
CD14+ Monocytes, donor2	11305-117B9	65.70	9.09	3.90	5.75	0.56	0.19	0.37	15.40
CD14+ Monocytes, donor3	11381-118B4	63.67	7.46	4.17	5.71	1.54	0.00	0.66	10.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	35.95	2.83	0.00	0.28	0.28	0.57	0.00	15.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.50	4.55	0.00	0.38	0.38	0.38	0.00	13.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	42.74	2.96	0.00	0.99	0.33	0.33	0.33	12.16
CD14+ monocytes - mock treated, donor1	11863-125A9	60.42	7.23	15.76	14.17	0.58	1.01	0.58	18.21
CD14+ monocytes - mock treated, donor2	11873-125C1	41.34	4.83	15.39	9.35	0.30	0.00	0.00	19.92
CD14+ monocytes - mock treated, donor3	11883-125D2	51.41	5.69	9.48	11.61	1.18	0.47	1.18	16.35
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	69.97	8.54	10.88	5.36	1.51	0.33	0.33	23.27
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	56.58	6.90	9.94	5.24	1.66	0.00	0.00	20.42
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	70.66	9.92	12.89	4.21	0.50	0.25	0.50	22.56
CD14+ monocytes - treated with BCG, donor1	11860-125A6	73.03	7.64	12.34	6.85	0.59	0.20	0.78	23.10
CD14+ monocytes - treated with BCG, donor2	11870-125B7	64.81	8.55	11.40	5.70	0.36	0.00	0.89	17.45
CD14+ monocytes - treated with BCG, donor3	11880-125C8	96.85	12.19	19.15	4.13	0.65	0.44	0.87	21.11
CD14+ monocytes - treated with Candida, donor1	11868-125B5	110.27	13.58	12.64	7.49	0.47	0.70	0.94	22.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	106.13	21.12	16.37	6.86	0.53	1.06	0.00	24.82
CD14+ monocytes - treated with Candida, donor3	11888-125D7	94.30	13.31	12.20	7.77	1.11	0.00	1.11	16.64
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	65.60	9.37	12.94	9.37	1.04	1.19	0.74	23.95
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	48.49	4.39	15.17	8.78	0.80	0.20	1.00	19.56
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.71	7.70	19.78	8.33	0.83	0.42	0.62	22.90
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	100.44	12.58	16.93	10.30	0.69	0.46	1.60	29.97
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	77.14	4.07	25.79	9.95	0.90	0.23	0.90	24.43
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	85.55	7.86	18.77	7.86	1.31	0.00	0.44	31.86
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	62.94	7.26	12.37	8.61	0.81	0.27	0.54	16.68
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	69.09	6.28	17.10	9.42	0.70	0.35	0.70	16.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	56.39	10.52	12.62	6.73	0.00	0.84	0.00	23.57
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	73.30	7.90	6.43	8.82	0.55	0.18	0.37	19.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	58.83	3.52	7.40	6.69	0.70	0.70	0.00	13.39
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	70.63	5.70	7.46	3.51	0.88	0.00	0.88	19.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	79.34	15.52	12.55	5.23	0.35	0.35	1.22	27.20
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	71.36	10.78	10.78	5.95	1.49	0.00	0.74	34.94
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	110.15	17.03	18.11	8.84	1.08	0.22	1.51	14.87
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	73.30	9.83	7.37	8.19	1.64	0.41	0.41	18.84
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	72.09	8.11	10.66	5.79	0.23	0.00	0.00	23.18
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	95.58	6.03	12.06	8.12	0.70	0.23	0.93	29.00
CD14+CD16+ Monocytes, donor1	11789-124B7	34.22	4.36	6.54	2.40	0.00	0.22	0.65	6.10
CD14+CD16+ Monocytes, donor2	11801-124D1	45.27	4.39	9.47	4.39	0.23	0.23	0.69	6.47
CD14+CD16+ Monocytes, donor3	11912-125G4	38.12	3.90	4.77	2.82	0.65	0.22	0.22	6.50
CD14+CD16- Monocytes, donor1	11788-124B6	69.14	6.70	7.47	4.98	0.47	0.47	0.31	8.10
CD14+CD16- Monocytes, donor2	11799-124C8	58.51	5.76	6.46	3.67	0.87	0.35	0.52	11.88
CD14+CD16- Monocytes, donor3	11910-125G2	57.30	5.35	3.79	5.13	0.00	0.22	0.00	12.26
CD14-CD16+ Monocytes, donor1	11790-124B8	38.79	7.66	6.63	1.53	0.77	0.26	1.28	3.57
CD14-CD16+ Monocytes, donor2	11800-124C9	39.08	3.73	5.93	1.32	0.44	0.88	0.00	6.59
CD14-CD16+ Monocytes, donor3	11911-125G3	39.37	5.26	6.11	2.11	0.42	0.00	0.00	5.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	28.45	16.26	0.00	0.00	0.00	4.06	2.03	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	41.36	18.31	0.00	0.00	0.00	2.71	0.68	7.46
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	51.78	18.64	0.00	0.00	0.00	1.04	2.07	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	41.04	19.72	0.53	0.53	0.00	1.60	2.13	13.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	48.78	17.69	0.00	0.00	1.07	2.14	3.22	9.11
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	26.67	18.95	0.00	0.00	0.00	2.11	2.11	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	40.00	12.55	0.00	0.00	0.00	0.78	3.14	8.63
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	39.55	19.77	0.00	0.00	0.00	2.64	1.32	3.95
CD19+ B Cells, donor1	11544-120B5	30.41	23.84	0.82	0.00	0.00	1.64	2.47	8.22
CD19+ B Cells, donor2	11624-122B4	21.76	21.04	0.00	0.00	0.00	0.73	0.00	8.71
CD19+ B Cells, donor3	11705-123B4	31.30	16.66	0.00	0.00	1.01	2.02	2.02	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	75.15	15.35	0.81	0.00	0.00	0.40	0.40	22.63
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	54.73	11.19	0.00	0.00	0.40	0.40	0.80	19.58
CD34+ Progenitors, donor1	11545-120B6	27.11	7.03	0.00	0.00	0.00	1.00	1.00	3.01
CD34+ Progenitors, donor2	11625-122B5	43.26	10.11	2.81	0.56	0.56	0.00	1.12	3.93
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	34.57	6.76	0.38	0.00	0.38	0.00	0.75	6.39
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	38.78	3.83	2.03	1.58	0.00	0.45	0.23	7.44
CD4+ T Cells, donor1	11225-116C1	67.13	19.64	0.36	1.07	0.00	1.07	1.79	13.93
CD4+ T Cells, donor2	11306-117C1	41.03	21.43	1.22	0.61	1.22	1.22	1.84	18.98
CD4+ T Cells, donor3	11382-118B5	45.14	11.28	2.44	0.91	0.30	1.22	2.44	12.50
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	43.90	12.25	0.00	0.77	0.51	1.79	1.02	4.59
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	46.27	10.56	0.00	0.22	0.22	1.35	1.57	13.70
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	56.92	14.66	0.86	0.29	0.00	1.15	1.72	12.07
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	66.85	18.02	0.95	0.00	0.47	1.42	4.27	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	75.15	23.18	0.00	0.00	0.70	2.81	0.70	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	32.96	0.00	0.00	0.00	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	45.09	9.54	0.72	0.87	0.58	1.73	1.16	8.82
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	42.03	8.30	0.85	0.17	0.51	1.02	1.19	11.35
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	37.24	8.06	0.32	0.48	0.64	1.13	1.29	10.80
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	51.55	17.04	1.79	0.45	0.45	0.90	2.24	10.31
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	56.60	17.82	0.35	0.70	1.05	1.40	2.80	8.04
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	62.04	12.32	0.00	0.00	0.00	0.88	1.76	10.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	43.43	7.59	0.00	0.42	0.00	1.26	1.26	12.23
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	37.40	7.27	1.04	0.83	0.42	0.83	0.21	18.91
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	31.41	10.02	0.33	0.00	0.33	0.00	1.67	11.36
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	66.90	20.40	1.09	0.27	0.00	1.63	1.63	8.70
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.92	18.22	1.61	0.54	0.00	2.14	2.14	9.11
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	55.59	8.97	1.79	0.00	0.00	1.79	5.38	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	47.84	8.16	0.00	0.37	0.19	1.30	1.11	14.09
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.29	11.48	0.65	0.65	0.43	0.22	1.52	7.36
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.12	10.72	0.63	0.21	0.84	1.05	1.05	6.51
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	52.58	15.67	0.51	0.51	0.51	1.52	4.04	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	51.12	10.83	0.87	0.00	1.30	0.43	0.87	4.33
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	51.86	10.02	0.00	0.44	0.00	0.87	0.44	12.20
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	69.78	23.75	0.99	0.99	0.49	2.97	1.48	7.92
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	51.70	12.92	0.00	0.00	0.00	0.92	4.62	7.39
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	55.83	15.35	0.00	0.00	0.00	1.40	4.19	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	48.19	14.95	0.55	0.00	0.28	1.38	1.94	4.71
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	53.25	15.71	0.00	0.00	0.25	1.47	2.21	7.85
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	46.20	12.32	0.00	1.54	0.00	3.08	0.00	18.48
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	51.57	16.12	0.72	0.72	0.36	2.15	1.79	11.10
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	67.86	15.23	0.00	0.00	0.00	1.38	1.38	9.69
CD8+ T Cells, donor1	11226-116C2	46.16	20.95	1.31	0.33	0.00	2.29	1.96	9.49
CD8+ T Cells, donor2	11307-117C2	37.17	16.14	1.13	0.38	1.13	0.00	1.88	10.14
CD8+ T Cells, donor3	11383-118B6	55.30	18.94	1.26	0.50	1.51	0.76	1.01	10.60
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	24.54	1.84	0.23	0.00	0.00	0.69	1.61	5.51
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.77	4.31	0.48	0.00	0.00	0.00	0.24	4.55
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.98	5.20	1.09	0.27	0.00	1.09	0.27	5.20
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.31	3.90	1.20	0.90	0.00	0.30	0.60	8.11
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.48	5.28	1.44	0.72	0.48	0.00	0.72	6.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.74	4.55	0.68	0.00	0.23	0.68	0.91	5.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	22.16	2.17	0.43	0.65	0.22	0.22	0.65	7.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	19.21	4.47	0.79	0.26	0.26	0.26	0.00	9.21
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.56	3.75	0.70	0.23	0.00	0.47	0.47	6.10
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	22.94	6.04	1.81	0.30	0.30	0.30	0.60	8.45
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	23.53	4.07	1.74	0.29	0.00	0.00	0.29	7.84
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.31	3.46	0.80	0.53	0.00	0.27	1.33	4.26
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	29.77	7.00	2.19	1.31	0.88	0.00	0.44	7.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	31.88	5.47	0.46	0.91	0.00	0.00	0.00	4.10
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	4.48	2.98	0.00	0.75	0.00	1.49	8.20
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	22.33	5.76	2.16	0.00	0.00	1.08	1.08	6.84
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.13	6.33	0.86	1.15	0.00	0.29	0.58	6.62
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	22.16	5.19	1.41	0.47	0.24	0.24	0.24	7.07
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.67	5.07	1.58	0.32	0.00	0.00	0.00	8.56
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	22.45	4.31	1.23	0.00	0.62	0.31	0.00	8.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.31	4.17	0.00	0.00	0.00	0.00	1.60	6.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.92	6.12	1.53	0.76	0.00	0.00	0.00	10.71
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	28.38	5.52	1.58	1.18	0.39	0.79	0.00	9.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.21	6.05	3.03	1.51	1.51	0.76	0.76	9.08
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	58.62	6.42	4.01	1.61	0.80	0.00	0.00	19.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	58.05	12.59	2.80	0.00	0.00	0.00	0.70	19.58
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	56.10	7.01	0.00	2.00	3.01	0.00	0.00	16.03
Cardiac Myocyte, donor1	11525-119I4	29.24	10.97	3.66	1.83	3.66	0.00	1.83	5.48
Cardiac Myocyte, donor2	11605-120I3	35.57	6.42	1.48	0.49	0.00	0.00	0.99	9.39
Cardiac Myocyte, donor3	11686-122I3	62.51	7.68	1.16	0.42	0.11	0.63	0.53	15.36
Chondrocyte - de diff, donor1	11261-116G1	30.51	7.28	7.63	0.00	0.69	0.00	0.69	21.15
Chondrocyte - de diff, donor2	11338-117F6	25.94	6.75	5.69	1.78	0.71	0.36	1.07	10.31
Chondrocyte - de diff, donor3	11410-118E6	39.48	6.83	5.01	2.28	0.57	0.34	0.23	20.94
Chondrocyte - re diff, donor2	11339-117F7	51.92	14.32	17.91	5.37	0.90	0.90	0.00	11.64
Chondrocyte - re diff, donor3	11411-118E7	41.25	8.49	4.85	3.64	0.00	0.00	0.00	5.66
Ciliary Epithelial Cells, donor1	11242-116D9	58.53	10.90	5.51	1.15	0.11	0.34	0.34	20.20
Ciliary Epithelial Cells, donor2	11323-117D9	44.04	6.63	3.63	1.07	0.00	1.07	0.00	19.24
Ciliary Epithelial Cells, donor3	11399-118D4	42.39	9.29	2.12	1.15	0.00	0.62	0.35	12.04
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	55.75	7.43	0.46	0.55	0.55	0.83	1.19	8.80
Corneal Epithelial Cells, donor1	11526-119I5	22.40	3.95	0.00	0.44	0.44	0.00	0.44	5.05
Corneal Epithelial Cells, donor2	11606-120I4	20.48	3.41	0.00	0.00	0.00	0.00	0.00	30.72
Corneal Epithelial Cells, donor3	11687-122I4	33.23	6.90	0.26	0.26	0.26	0.00	0.00	8.69
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	39.79	3.80	1.82	2.97	0.00	0.83	0.00	14.53
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	48.26	4.73	1.26	4.73	0.00	0.32	0.63	13.56
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	3.45	3.45	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	28.51	4.54	1.51	2.70	0.32	0.54	0.11	8.42
Dendritic Cells - plasmacytoid, donor1	11228-116C4	47.15	4.10	0.68	0.68	0.00	0.68	0.34	10.93
Dendritic Cells - plasmacytoid, donor2	11309-117C4	54.19	2.61	1.31	0.00	0.65	1.31	0.65	5.22
Dendritic Cells - plasmacytoid, donor3	11385-118B8	27.58	6.29	0.00	0.00	0.48	0.00	0.00	4.36
Endothelial Cells - Aortic, donor0	11207-116A1	48.70	3.67	1.33	1.50	0.83	0.50	0.17	14.18
Endothelial Cells - Aortic, donor1	11263-116G3	20.54	1.17	2.35	1.76	0.00	0.59	0.00	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	36.20	3.96	1.98	1.98	0.00	0.57	0.00	14.42
Endothelial Cells - Aortic, donor3	11412-118E8	66.84	5.90	1.57	2.36	0.39	0.00	0.00	9.04
Endothelial Cells - Artery, donor1	11264-116G4	27.63	3.20	2.62	1.45	0.00	0.00	0.00	2.62
Endothelial Cells - Artery, donor2	11341-117F9	35.29	4.00	3.53	1.88	0.47	0.00	0.24	14.59
Endothelial Cells - Artery, donor3	11413-118E9	38.92	3.86	2.28	2.10	1.23	0.53	0.00	6.84
Endothelial Cells - Lymphatic, donor1	11236-116D3	56.08	5.76	2.66	1.33	0.22	0.44	0.44	12.63
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.16	3.65	3.04	1.22	0.30	0.61	0.00	7.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	70.19	7.61	2.82	3.38	0.00	0.56	0.00	8.18
Endothelial Cells - Microvascular, donor1	11265-116G5	28.23	3.86	2.67	0.00	0.00	0.30	0.00	9.81
Endothelial Cells - Microvascular, donor2	11342-117G1	33.84	2.08	1.56	3.12	0.52	0.00	0.00	7.81
Endothelial Cells - Microvascular, donor3	11414-118F1	34.17	2.41	0.85	0.43	0.28	0.00	0.14	7.66
Endothelial Cells - Thoracic, donor1	11266-116G6	35.61	4.80	3.20	2.00	0.40	0.00	0.00	26.01
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	3.67	0.52	0.00	0.00	0.00	0.52	12.58
Endothelial Cells - Umbilical vein, donor1	11243-116E1	100.52	8.70	2.61	3.48	0.37	0.99	0.75	22.61
Endothelial Cells - Umbilical vein, donor2	11324-117E1	59.10	4.56	1.09	1.30	0.22	0.43	0.00	10.86
Endothelial Cells - Umbilical vein, donor3	11400-118D5	59.35	6.96	0.85	0.73	0.24	0.24	0.61	9.65
Endothelial Cells - Vein, donor1	11267-116G7	18.20	2.28	1.14	0.00	0.00	0.00	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	24.45	4.89	0.70	1.40	2.10	0.00	0.00	3.49
Endothelial Cells - Vein, donor3	11416-118F3	40.82	3.61	1.73	1.73	0.63	0.31	0.16	6.91
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	161.73	70.96	1.65	3.30	0.00	1.65	1.65	8.25
Eosinophils, donor3	12246-129H5	149.81	46.37	0.00	0.00	0.00	0.00	0.00	17.83
Esophageal Epithelial Cells, donor1	11507-119G4	34.45	5.38	0.00	0.24	0.00	0.24	0.00	8.06
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	2.08	0.00	0.00	0.00	0.00	0.00	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	81.34
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	40.64	9.44	2.05	0.82	0.82	0.82	0.41	26.68
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	29.34	4.82	1.97	1.31	1.09	0.33	0.44	5.26
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	39.76	8.02	3.25	0.65	0.98	0.43	0.54	14.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	55.18	6.43	3.03	2.06	0.97	0.85	0.61	15.65
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	73.29	13.24	3.14	1.77	0.55	1.50	1.09	9.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	45.35	6.86	0.95	1.90	0.21	0.21	0.53	14.87
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.83	11.59	1.84	1.32	0.53	1.58	1.05	7.38
Fibroblast - Aortic Adventitial, donor3	11401-118D6	38.87	12.96	3.32	2.99	0.33	0.33	0.33	12.62
Fibroblast - Cardiac, donor1	11268-116G8	31.30	8.62	0.91	0.91	0.45	0.45	0.00	7.71
Fibroblast - Cardiac, donor2	11345-117G4	31.83	4.55	0.76	0.00	0.76	0.00	0.00	9.85
Fibroblast - Cardiac, donor3	11417-118F4	20.19	2.68	0.47	0.47	0.32	0.47	0.00	4.89
Fibroblast - Cardiac, donor4	11452-119A3	75.47	8.79	1.52	1.21	0.00	0.30	0.30	8.49
Fibroblast - Cardiac, donor5	11456-119A7	55.33	6.85	1.90	1.52	0.63	0.89	0.38	10.03
Fibroblast - Cardiac, donor6	11460-119B2	44.11	6.06	2.43	0.30	0.00	0.00	0.15	9.85
Fibroblast - Choroid Plexus, donor1	11492-119E7	29.34	6.03	1.34	0.40	0.40	0.27	0.54	10.85
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.53	4.31	2.16	0.43	0.43	0.43	0.86	8.20
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	2.93	1.46	0.00	0.00	0.00	1.46	17.58
Fibroblast - Conjunctival, donor1	11531-120A1	35.29	6.46	0.00	0.23	0.23	0.92	0.00	8.53
Fibroblast - Conjunctival, donor3	11692-122I9	65.13	6.95	3.05	0.68	0.17	0.17	0.34	14.76
Fibroblast - Dermal, donor1	11269-116G9	40.62	5.63	1.88	1.41	0.23	0.00	0.23	7.51
Fibroblast - Dermal, donor2	11346-117G5	22.17	4.25	2.83	0.94	0.00	0.47	0.94	7.55
Fibroblast - Dermal, donor3	11418-118F5	43.52	7.25	1.09	0.97	0.48	0.60	0.36	15.11
Fibroblast - Dermal, donor4	11450-119A1	46.91	7.57	1.36	1.58	0.23	0.45	0.79	10.29
Fibroblast - Dermal, donor5	11454-119A5	42.57	6.80	0.17	0.17	0.52	0.00	0.17	9.07
Fibroblast - Dermal, donor6	11458-119A9	42.23	5.85	0.97	0.65	0.00	0.16	0.16	9.91
Fibroblast - Gingival, donor1	11237-116D4	60.59	8.75	1.46	0.42	0.21	0.62	0.42	13.74
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	85.67	16.24	2.88	1.31	3.41	1.05	0.26	8.65
Fibroblast - Gingival, donor2	11318-117D4	42.04	4.61	0.40	1.05	0.13	0.40	0.26	17.79
Fibroblast - Gingival, donor3	11394-118C8	76.58	9.19	0.87	1.64	0.10	1.06	0.68	11.70
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	67.53	14.54	4.16	0.00	1.04	1.04	0.00	25.97
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	42.82	8.99	2.64	0.35	0.18	0.70	0.18	27.84
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	52.54	8.42	1.40	1.09	0.16	0.78	0.78	11.54
Fibroblast - Gingival, donor6 (control)	11922-125H5	49.09	9.60	2.16	1.62	0.95	0.54	0.41	11.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	49.05	10.59	0.00	0.00	0.35	1.06	1.76	3.53
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.26	9.21	2.19	0.88	0.58	0.15	0.44	10.68
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.86	9.41	3.00	1.50	0.14	0.41	0.27	15.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	51.34	9.21	2.52	0.66	0.44	0.55	0.77	11.41
Fibroblast - Gingival, donor9 (control)	11927-125I1	102.57	16.29	7.04	1.17	6.31	1.17	0.88	16.87
Fibroblast - Lung, donor1	11270-116H1	16.31	2.72	0.00	0.00	2.72	0.00	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	61.18	14.92	0.00	2.98	0.00	1.49	0.00	10.45
Fibroblast - Lung, donor3	11419-118F6	37.78	5.28	0.42	1.06	0.00	0.42	0.00	11.82
Fibroblast - Lymphatic, donor1	11506-119G3	26.66	9.16	0.00	1.67	0.00	0.00	0.00	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	6.99	1.40	0.00	0.00	0.00	0.00	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	8.12	1.96	0.00	0.28	0.28	0.00	0.00	1.68
Fibroblast - Mammary, donor1	11540-120B1	44.25	7.71	0.41	0.00	0.00	0.41	0.41	4.87
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	7.99
Fibroblast - Mammary, donor3	11701-123A9	29.78	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	44.81	6.79	1.16	1.36	0.39	0.39	0.78	22.50
Fibroblast - Periodontal Ligament, donor2	11319-117D5	50.66	8.19	0.91	0.91	0.61	0.76	0.46	12.74
Fibroblast - Periodontal Ligament, donor3	11395-118C9	69.46	8.87	1.84	1.84	0.31	0.92	1.53	4.90
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	39.31	8.40	4.20	1.53	0.38	0.38	0.00	11.07
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	42.39	7.29	1.62	0.54	0.27	0.00	0.27	19.98
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.66	7.19	2.55	0.70	0.58	0.93	0.35	11.48
Fibroblast - Pulmonary Artery, donor1	11250-116E8	45.21	6.63	1.88	0.99	0.22	0.44	0.44	20.23
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	39.22	6.71	0.00	0.20	0.00	0.41	0.61	6.71
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	2.00	0.00	0.00	0.00	0.00	0.67	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	27.28	1.19	1.19	1.19	0.00	0.00	0.79	11.86
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	50.80	12.70	3.57	0.40	0.20	0.99	0.99	5.95
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	53.46	6.75	3.20	1.24	0.71	0.18	0.53	19.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	66.42	10.45	5.32	1.77	0.00	1.58	0.59	19.91
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	51.15	14.74	2.11	0.30	0.60	1.20	0.90	6.62
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	61.32	11.77	6.37	1.51	0.43	0.11	0.54	18.89
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	57.19	13.41	2.78	0.76	0.25	0.76	0.25	8.35
Fibroblast - skin normal, donor1	11553-120C5	54.47	8.20	3.12	2.30	0.33	0.49	0.49	12.63
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	87.82	14.04	3.41	1.00	0.40	1.20	0.60	13.43
Fibroblast - skin normal, donor2	11561-120D4	51.14	12.76	6.03	2.21	0.20	0.30	0.60	14.17
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	68.00	22.06	3.63	2.12	0.30	0.00	2.72	11.18
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	78.54	10.02	5.55	1.16	0.66	0.41	0.50	27.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.34	5.30	1.88	0.85	0.00	0.00	1.03	18.12
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	42.70	19.38	3.94	0.99	1.64	0.66	0.33	11.17
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	53.05	9.27	7.24	1.28	0.43	0.64	0.64	17.26
Fibroblast - skin walker warburg, donor1	11554-120C6	43.86	5.57	2.36	1.01	0.17	0.17	0.34	16.70
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	39.68	5.96	5.18	2.04	0.31	0.16	0.47	15.53
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	44.32	66.48	22.16	0.00	0.00	0.00	155.12
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	149.03	33.99	3.49	0.87	4.36	0.00	2.61	18.30
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	71.94	10.92	3.81	0.69	0.87	0.35	0.17	21.67
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	82.24	11.45	4.68	2.86	1.04	0.78	0.26	30.71
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	57.75	10.48	1.79	1.79	0.51	0.77	0.51	15.84
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.79	2.30	0.00	0.00	0.77	0.00	0.00	9.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	2.55	2.55	0.00	0.64	1.91	1.28	26.80
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	36.23	7.42	1.14	0.29	0.86	1.14	1.14	37.94
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	52.67	9.93	0.83	0.00	1.65	0.00	0.28	28.95
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	44.52	5.25	2.28	0.23	1.60	1.37	0.91	24.20
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	35.27	8.52	0.40	0.00	0.79	0.40	0.20	23.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.62	6.08	0.00	0.00	1.85	0.26	0.53	30.93
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	49.90	7.50	1.96	0.33	1.30	0.65	1.63	20.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	36.26	8.84	2.65	0.00	0.44	1.77	2.65	38.92
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	33.21	6.78	0.42	0.00	0.14	1.27	1.13	12.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	42.48	7.27	0.49	0.12	0.12	0.99	1.11	8.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	29.55	7.79	1.61	0.00	0.54	0.27	1.07	17.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	47.95	7.31	0.37	0.25	0.50	0.99	0.37	10.53
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.89	12.74	0.42	0.14	0.83	1.52	1.52	12.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	50.01	8.34	0.61	0.00	0.61	0.61	0.41	22.57
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	47.46	10.50	0.91	0.00	0.00	0.46	1.14	23.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.17	8.72	1.25	0.62	0.75	0.87	0.87	10.34
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	56.83	8.96	0.87	0.00	1.09	0.87	0.44	12.02
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	36.64	6.50	0.00	0.00	1.18	1.18	0.00	14.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.81	5.88	0.95	0.00	0.32	0.64	0.64	9.06
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.56	7.15	1.12	0.22	0.89	0.45	0.89	10.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	28.03	5.04	0.60	0.20	0.60	1.21	0.60	17.74
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.55	6.28	0.34	0.00	0.51	0.51	1.02	11.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	47.35	8.60	1.33	0.44	0.53	0.62	0.98	16.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.98	5.31	0.52	0.10	0.73	0.83	0.00	14.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.50	6.32	0.85	0.00	0.00	0.17	0.17	9.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.43	4.98	0.55	0.11	0.33	0.66	0.66	6.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.69	5.82	0.92	0.50	0.33	0.50	0.75	15.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.12	6.74	0.61	0.00	0.00	0.20	0.61	11.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.30	4.13	0.21	0.00	0.00	0.41	0.00	17.33
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.24	6.11	0.58	0.12	0.23	0.92	0.23	9.45
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.35	3.34	0.50	0.17	0.17	0.17	0.33	8.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	31.52	3.75	0.00	0.22	0.44	0.44	0.00	14.77
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	31.98	5.66	0.37	0.00	0.49	0.74	0.12	6.89
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	32.42	4.70	0.81	0.00	0.00	0.16	0.97	9.08
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.60	5.13	0.32	0.32	0.64	0.00	0.64	13.79
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	28.71	6.25	0.38	0.09	0.76	0.66	0.38	6.82
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.16	3.48	0.32	0.47	0.16	0.16	0.32	9.65
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	36.79	3.65	0.91	0.61	0.30	0.30	0.00	15.81
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.43	6.38	0.63	0.00	0.21	0.73	0.42	11.29
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.64	5.49	0.66	0.44	0.44	0.22	1.10	9.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	33.67	5.05	0.56	0.84	0.56	0.84	1.12	16.27
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.76	5.37	0.56	0.00	0.74	0.93	0.00	4.81
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.60	3.74	0.80	0.27	0.00	0.00	0.00	14.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.31	3.37	1.07	0.77	0.00	0.15	0.46	14.99
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.83	2.85	0.39	0.26	0.26	0.00	0.13	7.64
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.82	3.80	0.54	0.54	0.54	0.81	0.81	10.57
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	24.33	4.24	0.92	0.37	0.55	0.00	0.55	14.01
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	28.51	3.95	0.00	0.22	0.00	0.44	0.44	11.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	34.71	6.94	0.00	0.00	0.99	2.98	0.99	11.90
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.81	4.22	0.79	0.26	0.13	0.40	0.40	14.77
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.82	4.64	1.21	0.20	0.20	0.40	0.81	15.33
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.21	5.08	0.76	0.00	0.00	0.76	0.51	9.91
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	33.64	6.77	0.60	0.00	0.00	0.20	0.20	16.92
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	37.59	6.63	0.31	0.00	0.62	0.62	0.77	10.94
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	27.00	6.75	0.82	0.00	0.00	0.82	1.64	11.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	25.66	6.26	1.25	0.00	0.00	0.63	0.63	8.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	25.43	3.39	0.57	0.00	0.00	0.00	0.85	11.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	18.91	6.92	0.92	0.00	0.92	1.38	0.46	15.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	4.95	0.00	0.00	7.42	0.00	0.00	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	29.40	7.74	0.77	0.00	1.16	0.39	1.55	15.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	19.25	4.81	1.60	0.00	1.60	0.00	0.00	40.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	13.91	1.74	1.74	5.22	0.00	1.74	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	21.16	3.58	0.33	0.33	0.98	1.30	0.00	18.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	25.12	5.77	1.24	0.00	2.06	0.41	0.82	16.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	6.66	0.00	0.00	3.33	0.00	3.33	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	23.77	4.19	0.56	0.00	0.56	0.84	0.84	16.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.92	3.60	0.65	0.00	0.65	0.98	0.33	18.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	16.78	5.87	0.00	0.00	1.68	0.00	0.84	15.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	23.22	7.00	0.95	0.00	0.32	0.64	0.95	15.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.74	4.42	0.00	0.00	0.68	0.34	0.68	19.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	29.23	6.26	0.00	0.00	0.00	0.00	0.00	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	23.48	7.45	0.57	0.00	0.00	0.00	0.00	16.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.83	3.55	0.00	0.00	0.00	0.59	0.00	18.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	10.16	0.00	0.00	1.69	0.00	0.00	11.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	22.78	3.31	0.41	0.00	1.24	0.00	1.24	14.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	23.01	2.99	0.23	0.00	1.38	0.00	0.23	13.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	0.00	0.00	0.00	0.00	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	22.30	3.84	0.38	0.00	1.15	0.00	1.15	20.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	29.01	3.91	0.33	0.00	0.98	0.00	0.00	15.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	24.75	4.01	0.67	0.00	1.34	0.67	0.67	9.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	38.14	3.85	0.00	0.00	1.54	0.39	0.77	20.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	42.11	5.48	0.68	0.00	1.03	0.68	1.37	21.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	4.97	4.97	0.00	7.45	0.00	0.00	24.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	39.64	5.66	0.00	0.00	0.94	0.47	0.94	14.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.21	7.24	0.00	0.00	1.21	0.60	1.21	27.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	36.12	2.54	0.00	0.00	1.02	0.51	0.51	12.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	30.31	5.58	0.40	0.00	0.80	0.80	0.80	12.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	30.59	6.91	0.00	0.00	0.00	0.00	1.48	25.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	34.23	10.62	0.00	0.00	2.36	0.00	0.00	22.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.09	7.00	0.58	0.00	0.58	0.00	0.00	20.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.57	5.27	0.00	0.00	0.44	0.00	0.00	13.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.95	4.24	0.00	0.00	0.85	0.00	0.85	33.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	2.98	0.00	0.00	0.60	0.00	0.00	28.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	21.35	2.91	0.00	0.00	1.46	0.00	0.00	12.13
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	28.53	3.42	2.28	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.45	3.74	2.49	0.00	0.83	0.00	0.83	19.54
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	24.74	2.25	0.00	0.00	1.12	2.25	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.67	6.34	9.51	2.85	0.63	0.00	0.00	23.15
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	39.69	11.70	9.19	0.84	1.25	0.00	1.67	19.63
Hep-2 cells mock treated, biol_rep1	11898-125E8	25.18	3.48	0.12	0.23	0.12	0.35	0.12	10.10
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.53	3.71	0.84	0.34	0.00	0.34	0.00	10.13
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.30	5.69	0.00	0.23	0.00	0.23	0.91	12.74
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.61	4.26	0.33	0.44	0.44	0.22	0.00	11.04
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.51	7.09	0.64	0.21	0.21	0.21	0.00	10.10
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.47	3.88	1.08	0.22	0.22	0.00	0.86	8.83
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	25.03	3.99	0.25	0.12	0.25	0.25	0.00	8.97
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	20.59	2.74	0.34	0.34	0.34	0.69	0.34	9.09
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	22.75	2.56	0.32	0.00	0.00	0.32	0.00	8.01
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.38	7.83	0.56	0.00	0.56	0.00	0.00	8.95
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.39	0.87	0.00	0.00	0.43	0.87	0.43	6.06
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	2.64	0.00	13.22	0.00	0.00	0.00	52.88
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.57	2.82	0.00	0.00	0.00	0.35	0.00	7.05
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	2.91	0.00	0.00	0.00	0.73	0.00	8.72
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	33.92	6.47	0.87	0.35	0.00	0.17	0.00	12.76
Hepatocyte, donor1	11523-119I2	37.53	7.26	0.00	0.00	1.21	0.00	1.21	32.69
Hepatocyte, donor2	11603-120I1	21.55	2.15	0.00	0.00	0.00	1.08	1.08	30.17
Hepatocyte, donor3	11684-122I1	34.97	6.75	1.23	0.00	0.00	0.00	0.00	19.02
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.23	3.26	0.00	0.00	0.00	0.00	0.00	11.10
Intestinal epithelial cells (polarized), donor1	11246-116E4	44.74	5.77	1.05	0.52	0.00	1.22	0.52	23.60
Iris Pigment Epithelial Cells, donor1	11530-119I9	35.95	4.67	3.16	1.78	0.00	0.41	0.00	8.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	6.37	0.00	0.00	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	2.77	0.00	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	7.51	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	2.56	0.00	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	29.24	1.62	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	5.00	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	1.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	5.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	5.24	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.16	1.26	0.00	0.00	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	3.09	0.00	0.00	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.09	7.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	11.41	4.89	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.33	4.20	0.00	0.00	0.42	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	4.82	0.00	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.93	2.77	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.58	1.89	0.00	0.00	0.00	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	2.72	0.00	0.00	0.00	0.00	0.00	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	21.52	0.00	0.00	0.00	0.00	1.08	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	0.00	0.00	0.00	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	11.48	5.74	0.00	0.00	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	2.14	0.00	0.00	0.00	0.00	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	13.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.04	2.78	0.00	0.00	0.00	0.93	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.95	2.09	0.00	0.00	0.00	0.70	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	4.43	0.00	0.00	0.00	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	6.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	22.67	2.62	0.00	0.00	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	2.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	1.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	8.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	17.49	5.52	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	3.03	0.00	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	68.87	12.24	0.90	0.73	0.65	0.49	0.57	25.54
Keratinocyte - epidermal, donor2	11349-117G8	21.67	6.44	1.17	0.00	0.59	0.00	0.00	4.69
Keratinocyte - epidermal, donor3	11421-118F8	59.16	7.76	0.76	0.47	0.28	0.38	0.38	22.05
Keratinocyte - oral, donor1	11251-116E9	127.48	16.35	1.36	1.36	0.34	1.02	0.91	52.90
Keratocytes, donor1	11527-119I6	33.35	5.50	0.00	0.34	0.34	0.00	0.69	11.35
Keratocytes, donor2	11607-120I5	8.20	2.34	0.00	0.00	0.00	0.00	0.00	4.69
Keratocytes, donor3	11688-122I5	47.82	5.93	0.40	0.20	0.40	0.40	0.20	9.68
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	10.99	0.00	0.00	0.00	2.20	0.00	13.19
Lens Epithelial Cells, donor1	11529-119I8	28.05	4.31	2.16	1.08	0.00	0.00	1.08	20.50
Lens Epithelial Cells, donor2	11609-120I7	45.90	9.34	2.65	0.92	0.00	0.46	0.58	14.19
Lens Epithelial Cells, donor3	11690-122I7	46.22	8.68	2.72	1.21	0.10	1.31	0.61	5.15
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.22	3.56	3.56	1.42	0.24	0.36	0.47	10.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	26.23	4.19	2.23	1.40	0.00	0.00	0.28	11.72
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	47.70	6.14	3.46	2.52	0.47	0.31	0.16	17.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	26.35	6.99	2.15	0.54	0.00	0.00	0.00	23.66
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	23.01	1.26	2.52	0.63	0.32	0.32	0.32	8.19
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.05	2.80	2.26	1.19	0.11	0.11	0.11	11.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	28.73	4.92	2.46	1.64	0.41	0.00	0.00	20.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	22.25	2.78	0.51	0.76	0.25	0.25	0.00	8.60
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.88	3.10	2.25	1.55	0.42	0.28	0.00	12.67
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	26.90	1.58	4.75	2.37	0.00	0.40	0.00	25.71
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	32.77	5.04	2.33	2.13	0.00	0.00	0.19	13.18
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.66	1.67	0.93	0.74	0.00	0.19	0.00	6.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	29.96	3.14	0.35	0.70	0.00	0.00	0.00	19.86
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	25.52	3.82	2.62	0.72	0.95	0.00	0.00	11.45
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.25	2.88	1.79	0.69	0.14	0.00	0.14	12.64
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	39.11	4.00	3.39	1.23	0.62	0.00	0.00	28.95
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.02	3.12	1.56	1.56	0.00	0.31	0.31	3.74
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.21	2.20	1.83	1.10	0.00	0.37	0.00	11.35
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	33.24	4.94	2.96	1.65	0.00	0.33	0.33	23.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	20.79	2.05	2.64	0.88	0.29	0.00	0.00	4.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.42	3.98	0.75	1.00	0.25	0.00	0.00	7.72
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	31.52	4.36	2.91	1.94	0.48	0.00	0.97	18.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.58	6.73	1.89	1.62	0.00	0.54	0.54	14.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.00	4.54	2.12	1.51	0.15	0.00	0.00	15.29
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.88	3.63	2.59	2.07	1.04	0.00	0.00	22.81
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.25	6.91	3.14	2.09	0.00	0.63	0.21	11.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	28.87	2.71	3.31	1.35	0.30	0.00	0.30	10.98
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	6.88	6.88	2.75	0.00	0.00	0.00	21.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.68	4.33	2.45	2.26	0.00	0.00	0.38	9.78
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	20.89	3.29	2.65	0.64	0.11	0.32	0.11	10.07
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	32.47	7.27	1.45	0.48	0.48	0.48	0.97	29.07
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.49	2.65	3.64	2.65	0.00	0.00	0.00	12.90
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.32	2.60	1.36	1.12	0.00	0.25	0.25	9.54
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	33.32	4.81	5.55	1.85	0.37	0.37	0.37	23.32
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	33.36	6.42	2.96	2.22	0.25	0.49	0.00	13.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.37	2.34	1.51	2.75	0.14	0.14	0.14	10.17
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	32.49	6.75	3.54	0.96	0.00	0.32	0.00	23.80
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	42.00	5.78	3.65	3.35	0.00	0.30	0.30	15.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.11	5.88	3.78	1.96	0.00	0.42	0.28	16.10
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	28.80	6.40	3.91	0.36	0.36	0.00	0.00	20.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.48	2.42	0.97	0.48	0.48	0.00	0.00	7.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.38	2.80	1.24	1.09	0.16	0.16	0.00	4.82
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.29	4.30	2.51	0.72	0.00	0.00	0.00	17.91
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	29.07	2.29	2.94	0.00	0.00	0.65	0.33	9.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.60	1.41	0.71	0.47	0.24	0.00	0.24	5.89
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	32.92	4.83	3.59	3.22	0.12	0.12	0.37	8.66
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.70	1.02	0.51	0.00	0.00	0.26	0.00	8.20
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	22.08	3.58	1.19	1.79	0.00	0.30	0.00	8.06
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	36.26	2.27	0.00	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.08	6.14	0.00	0.77	0.00	0.00	1.53	6.14
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.81	7.42	0.00	0.00	0.00	0.00	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	26.23	7.19	0.00	0.00	0.00	0.00	1.27	6.77
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	5.63	0.00	0.70	0.00	0.00	0.70	8.44
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	5.60	0.00	0.00	0.00	0.93	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.19	6.18	0.00	0.00	0.52	0.00	0.00	5.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	5.95	0.00	0.00	0.00	0.00	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.31	8.14	0.23	0.00	0.00	0.00	0.45	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	25.30	8.72	0.29	0.00	0.29	0.58	0.58	20.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.76	7.65	0.90	0.00	0.00	0.00	0.90	14.41
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	35.50	8.54	0.14	0.14	0.41	0.68	0.68	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.60	6.68	0.00	0.00	0.00	1.54	0.51	8.73
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	29.99	8.82	0.00	0.00	0.35	0.35	0.71	10.94
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.32	6.00	0.67	0.00	0.67	0.00	1.33	7.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	30.56	6.62	0.00	0.00	0.00	1.02	0.51	8.15
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	37.62	8.54	0.27	0.00	0.80	0.00	0.27	12.01
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	36.84	6.24	0.19	0.00	0.00	0.38	1.13	11.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	23.32	6.75	0.00	0.00	1.23	1.23	0.61	6.14
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	42.40	8.97	0.00	0.00	0.00	0.00	0.82	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	34.98	11.66	0.21	0.00	1.04	0.62	0.83	16.45
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	35.03	8.41	0.56	0.00	0.56	0.00	0.00	26.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	38.12	3.09	0.00	0.00	0.00	0.00	0.00	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	40.93	9.87	0.29	0.00	0.29	0.29	0.58	18.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.69	8.37	0.00	0.00	0.60	0.30	0.60	17.64
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	32.64	7.19	0.00	0.00	0.00	0.00	0.55	16.04
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	34.64	7.42	1.41	0.00	0.71	0.00	0.71	3.89
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.50	5.90	0.00	0.00	1.48	1.11	1.48	10.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	5.76	0.00	0.00	0.00	0.00	0.00	6.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	21.49	8.44	0.00	0.00	0.38	0.00	0.00	5.76
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.34	7.93	0.00	0.57	0.00	0.00	1.13	6.23
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	5.74	0.00	0.00	0.00	0.82	0.00	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	28.02	9.04	0.00	0.00	0.00	0.00	0.90	4.52
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	24.42	5.75	0.00	0.00	0.00	0.00	0.00	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	29.13	8.22	0.00	0.00	0.75	0.00	0.75	6.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.75	10.03	0.74	0.00	0.00	0.37	0.74	5.20
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.98	6.46	0.86	0.00	0.00	0.00	0.43	15.51
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	21.41	4.28	0.00	0.00	0.00	0.00	0.86	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	26.65	7.33	1.00	0.00	0.67	0.67	0.67	8.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	21.72	1.81	0.60	0.00	0.00	0.60	1.21	10.26
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	2.84	0.00	0.00	0.00	1.42	0.71	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.72	7.56	0.00	0.00	0.00	0.00	0.69	5.50
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.79	5.90	0.00	0.00	1.07	0.00	0.00	6.98
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	24.24	6.06	0.00	0.00	0.00	0.67	0.67	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	38.52	7.78	0.00	0.37	0.00	0.37	0.74	6.67
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	5.81	0.00	0.00	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	20.10	4.23	0.00	0.00	0.00	0.00	0.00	4.23
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	35.21	8.40	0.00	0.00	1.20	0.40	1.20	7.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	30.53	7.27	0.00	0.00	0.00	0.00	0.00	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.96	7.67	0.00	0.00	0.00	0.00	0.77	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.66	7.89	0.99	0.00	0.49	0.00	0.49	4.93
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	6.59	0.00	0.00	0.94	0.00	0.94	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	34.69	6.54	0.00	0.50	0.50	0.50	1.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.25	9.46	0.00	0.00	0.45	0.00	0.90	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	8.61	0.00	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	31.17	8.46	0.00	0.00	0.45	0.00	0.45	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	35.58	6.26	0.00	0.00	0.39	0.39	0.39	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	3.30	0.00	0.00	0.66	1.32	0.66	4.62
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	36.32	8.30	0.00	0.00	0.52	0.00	1.56	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	41.57	9.63	0.00	0.00	0.44	0.88	0.88	4.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.02	10.62	0.56	0.56	0.00	0.00	0.56	8.39
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	38.42	10.16	0.00	0.00	0.00	0.88	0.00	7.95
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	35.49	8.10	0.00	0.00	0.77	0.77	0.39	7.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	32.41	3.04	0.00	0.00	0.51	0.51	0.51	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	36.53	7.69	0.00	0.48	0.96	0.48	0.48	6.25
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.59	7.55	0.00	0.00	0.40	0.40	0.40	10.34
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	10.33	0.00	0.00	1.22	0.00	0.00	8.51
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.83	8.99	0.00	0.00	0.00	0.00	0.00	5.53
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	37.62	6.84	0.00	0.00	0.38	0.00	0.00	6.46
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.30	6.71	0.00	0.52	0.00	0.00	0.52	8.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	14.51	4.84	0.00	0.00	0.00	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	40.56	6.02	0.00	0.00	0.32	0.00	0.95	10.77
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	6.93	0.00	0.00	1.07	0.53	1.07	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.99	10.92	0.57	0.00	0.00	1.15	0.00	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	37.54	10.28	0.00	0.00	0.00	0.51	1.03	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	25.46	7.07	0.00	0.00	0.71	0.00	0.00	6.37
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	8.51	0.00	0.00	0.00	0.00	0.57	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	29.54	6.66	0.00	0.00	0.00	1.66	0.00	3.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	27.41	9.40	0.00	0.00	0.00	0.78	1.57	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.21	3.76	0.00	0.00	0.42	0.00	0.84	4.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	28.81	6.04	0.00	0.00	0.00	0.46	0.00	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.08	4.68	0.00	0.00	0.00	0.00	0.67	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.73	12.30	0.00	0.00	0.00	1.07	0.00	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.27	6.87	0.00	0.00	0.00	0.00	1.62	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	4.59	0.00	0.00	0.00	0.92	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	7.11	0.00	0.00	0.00	0.00	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.76	7.98	0.57	0.00	0.57	0.00	0.00	5.70
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	4.60	0.77	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	24.62	7.66	0.00	0.00	0.55	0.00	0.55	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	27.17	7.57	0.89	0.00	0.45	0.00	0.00	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	33.79	7.80	0.00	0.00	0.52	1.04	0.26	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	26.52	5.97	0.00	0.00	0.00	0.00	0.00	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	41.57	6.24	0.00	0.00	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	34.87	2.05	0.23	0.68	0.00	0.23	0.23	11.62
Macrophage - monocyte derived, donor2	11313-117C8	34.32	5.69	0.92	1.47	0.18	0.55	0.37	8.81
Macrophage - monocyte derived, donor3	11389-118C3	35.00	6.55	0.39	0.66	0.39	0.79	0.13	8.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	46.20	8.50	2.12	1.59	1.06	0.00	0.00	7.43
Mallassez-derived cells, donor2	11929-125I3	55.46	6.65	3.49	1.58	0.32	0.00	0.48	17.11
Mallassez-derived cells, donor3	11930-125I4	55.32	9.73	2.78	1.81	0.28	0.69	0.56	16.68
Mammary Epithelial Cell, donor1	11273-116H4	161.22	28.20	1.69	5.08	0.70	1.89	1.20	64.57
Mammary Epithelial Cell, donor2	11350-117G9	103.95	18.53	1.45	1.74	0.29	0.29	0.29	25.77
Mammary Epithelial Cell, donor3	11422-118F9	22.95	5.49	0.00	0.00	0.00	0.25	0.25	4.74
Mast cell - stimulated, donor1	11487-119E2	165.42	26.44	30.51	18.98	0.68	1.36	0.68	16.27
Mast cell, donor1	11563-120D6	72.56	14.60	2.38	1.95	0.54	1.51	0.76	15.79
Mast cell, donor2	11565-120D8	114.11	16.05	3.57	7.13	1.78	0.30	2.97	11.59
Mast cell, donor3	11566-120D9	126.97	18.01	1.35	2.93	2.70	0.90	1.58	21.39
Mast cell, donor4	11567-120E1	102.65	18.26	2.13	1.77	3.37	2.30	1.77	23.93
Mast cell, expanded and stimulated, donor5	11940-126A5	53.78	8.54	1.77	7.43	0.11	0.67	0.89	10.42
Mast cell, expanded and stimulated, donor8	11942-126A7	55.45	12.26	2.33	9.34	1.17	0.58	0.00	16.93
Mast cell, expanded, donor5	11939-126A4	56.67	10.21	0.92	3.90	0.80	1.15	0.69	11.93
Mast cell, expanded, donor8	11941-126A6	43.18	7.36	0.33	1.67	0.67	0.67	0.50	10.21
Melanocyte - dark, donor1	11502-119F8	59.90	5.37	0.40	0.80	0.00	0.20	0.00	12.64
Melanocyte - dark, donor2	11582-120F7	47.76	3.46	1.04	0.69	0.00	0.00	0.00	12.81
Melanocyte - dark, donor3	11663-122F7	39.91	4.64	0.22	0.43	0.22	0.29	0.22	13.04
Melanocyte - light, donor1	11274-116H5	20.69	2.82	0.00	0.00	0.00	0.00	0.24	5.88
Melanocyte - light, donor2	11351-117H1	14.33	2.05	0.00	0.00	0.68	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	18.21	2.60	0.00	0.00	0.87	0.00	0.87	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	23.64	3.23	0.00	0.00	0.31	0.31	0.73	8.75
Melanocyte, donor2 (MC+2)	12739-135I3	28.24	3.50	0.00	0.27	0.27	0.00	0.54	16.67
Melanocyte, donor3 (MC+3)	12837-137B2	24.91	4.55	0.00	0.00	0.00	0.54	0.54	13.39
Meningeal Cells, donor1	11493-119E8	34.74	6.95	1.49	0.50	0.25	0.50	0.37	8.81
Meningeal Cells, donor2	11573-120E7	21.13	10.12	0.44	0.00	0.88	0.88	0.44	3.52
Meningeal Cells, donor3	11654-122E7	43.85	7.99	6.60	2.04	0.24	0.41	0.49	21.19
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	57.60	12.55	0.57	1.43	0.57	0.86	0.57	18.82
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	59.07	7.75	2.62	1.61	0.20	0.40	0.50	15.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	3.94	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	37.32	7.89	0.72	0.72	0.00	1.44	0.00	10.05
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	37.06	7.62	1.06	0.42	0.42	0.21	0.64	14.40
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.17	6.53	0.50	0.00	0.50	0.00	0.00	28.65
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.90	4.83	0.44	0.22	0.44	0.66	0.00	6.15
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.11	6.58	0.00	0.00	0.73	0.00	0.73	7.31
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.39	3.89	0.20	0.41	0.20	0.20	0.00	3.07
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	46.26	8.03	4.85	1.11	0.14	0.14	0.14	9.70
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	4.09	0.74	0.00	0.00	0.37	0.00	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	76.97	8.82	1.18	0.66	0.00	0.53	0.13	28.81
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.76	2.67	1.19	0.89	0.00	0.00	0.30	3.86
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	2.34	0.00	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.98	2.56	0.64	0.00	0.00	0.00	0.00	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	38.63	5.32	1.06	3.19	0.35	0.71	0.71	21.98
Mesenchymal stem cells - hepatic, donor0	11218-116B3	67.24	6.25	0.94	0.63	0.00	1.25	0.63	19.08
Mesenchymal stem cells - umbilical, donor0	11214-116A8	36.28	12.34	0.00	0.73	0.00	0.00	0.00	13.79
Mesothelial Cells, donor1	11247-116E5	40.84	7.96	2.92	2.65	0.00	0.27	1.33	15.38
Mesothelial Cells, donor2	12156-128G5	39.54	7.01	4.00	3.00	0.00	1.00	0.50	6.51
Mesothelial Cells, donor3	11402-118D7	37.29	5.20	3.04	2.38	0.36	0.65	0.51	13.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	2.70	0.00	0.00	0.00	1.35	0.00	14.85
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	31.28	3.94	0.25	0.74	0.00	0.25	0.00	10.34
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	28.27	4.12	0.29	1.18	0.29	0.59	0.59	6.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.97	2.79	0.31	0.31	0.31	0.62	0.00	9.61
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	27.80	3.53	0.41	1.24	0.21	0.21	0.00	6.22
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	26.28	1.75	0.50	0.25	0.00	0.25	0.25	9.01
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	37.70	4.19	0.00	0.93	0.93	0.93	0.93	5.12
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.61	3.66	0.20	0.20	0.20	0.00	0.00	9.14
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	28.51	3.56	0.00	0.79	0.00	0.40	0.00	3.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	26.55	3.54	0.00	0.00	1.77	0.88	0.00	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	25.08	4.56	1.52	1.14	0.00	0.76	0.00	10.26
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	6.58	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	23.77	1.70	0.64	0.42	0.00	0.00	0.21	7.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	1.84	0.00	0.00	0.00	0.92	0.92	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	22.65	2.38	0.30	0.30	0.00	0.30	0.30	9.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	5.03	0.00	0.00	1.68	1.68	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	27.60	2.26	0.75	0.25	0.25	0.00	0.50	7.78
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.47	4.28	2.14	1.19	0.00	0.00	0.00	7.13
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	16.59	3.87	0.00	0.00	0.00	0.55	0.00	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	26.02	2.30	1.15	0.92	0.00	0.00	0.00	15.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	27.55	4.63	0.63	0.63	0.00	0.21	0.21	5.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.68	3.47	0.61	0.61	0.20	0.20	0.00	4.08
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.81	2.57	1.07	0.86	0.00	0.21	0.00	13.09
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.01	3.11	0.22	0.22	0.00	0.67	0.00	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	21.46	3.07	0.22	0.44	0.00	0.22	0.00	8.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.73	2.03	0.51	0.51	0.51	0.00	0.00	3.55
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.66	2.72	1.63	0.82	0.00	0.27	0.54	9.24
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	29.41	3.82	0.59	0.29	0.00	0.29	0.00	5.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	0.00	0.00	0.00	0.00	0.00	0.00	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	25.95	1.44	0.96	0.96	0.48	0.00	0.00	13.46
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	33.62	4.80	0.80	1.20	0.00	0.40	1.20	5.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	1.37	0.00	0.00	0.00	0.00	0.00	6.86
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	20.52	1.50	0.00	0.50	0.00	1.00	0.50	11.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	0.00	0.00	0.00	0.00	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.83	3.07	0.00	0.44	0.00	0.88	0.00	11.82
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	12.14	0.00	1.10	0.00	0.00	1.10	5.52
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	1.92	0.00	0.00	0.00	0.00	0.00	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.06	1.49	1.24	0.74	0.74	0.00	0.00	13.88
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	4.18	0.00	0.70	0.00	0.00	0.00	3.48
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	0.00	0.00	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	17.78	4.10	0.34	0.00	0.00	0.00	0.00	10.60
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	16.63	4.38	0.44	0.44	0.00	0.44	0.00	3.50
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.01	1.78	0.00	0.00	0.00	0.71	0.36	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	19.08	3.93	0.28	0.56	0.00	0.00	0.00	11.78
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	25.77	4.16	0.00	0.00	0.00	0.00	0.42	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	1.75	0.58	0.00	0.00	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.10	1.81	0.30	0.30	0.00	0.30	0.00	10.86
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	29.22	5.01	1.25	0.42	0.00	1.25	0.00	8.35
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	14.44	0.00	0.00	0.00	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	0.92	0.00	0.00	0.00	0.00	0.00	10.16
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	29.59	2.85	0.57	0.57	0.57	0.00	0.57	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.99	1.93	0.97	0.14	0.41	0.00	0.41	2.49
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.55	2.33	0.52	0.78	0.00	0.26	0.26	10.37
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.87	3.00	0.00	1.29	0.00	0.00	0.00	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.69	2.54	0.00	0.64	0.00	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.81	2.14	0.27	0.53	0.00	0.27	0.27	6.67
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.33	2.99	0.90	0.60	0.00	0.60	0.30	7.48
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.00	2.12	0.14	0.42	0.00	0.00	0.14	1.70
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	25.16	2.87	0.00	0.96	0.00	0.00	0.00	11.78
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	32.51	3.76	0.22	1.11	0.44	0.44	0.22	5.75
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.79	1.90	0.00	0.00	0.00	0.00	0.38	2.65
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	23.30	3.98	0.85	0.28	0.00	0.00	0.00	15.91
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	30.97	5.16	1.47	1.47	0.00	0.00	0.25	6.88
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	1.30	0.00	0.00	0.00	0.00	0.00	3.91
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.46	3.53	0.88	0.29	0.00	0.59	0.29	12.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	30.56	4.61	2.59	1.73	0.00	0.58	0.29	8.36
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.96	1.65	2.06	2.06	0.00	0.00	0.00	19.78
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	23.23	1.19	0.89	2.08	0.00	0.30	0.00	7.74
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	0.00	0.00	0.00	0.00	0.00	0.00	33.90
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	0.00	0.00	0.00	0.00	0.00	1.78	16.04
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.70	1.31	0.33	0.66	0.00	0.00	0.00	12.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	2.10	0.00	1.05	0.00	1.05	0.00	13.68
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.78	1.78	0.40	1.38	0.00	0.00	0.20	6.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	3.73	0.00	0.93	0.00	0.00	0.00	13.04
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.65	2.63	0.00	0.38	0.00	0.00	0.00	11.27
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	11.72	2.13	0.00	0.27	0.27	0.00	0.00	6.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	19.57	1.36	0.23	0.34	0.11	0.23	0.11	5.88
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	17.68	3.68	0.00	0.00	0.00	0.74	0.00	11.05
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.59	0.73	0.00	0.00	0.37	0.00	0.00	12.09
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	1.56	1.56	0.00	0.00	0.00	0.00	20.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	22.45	1.60	0.00	0.53	0.53	0.00	0.00	8.55
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00	3.86	0.00	0.00	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	1.01	1.01	0.00	2.02	0.00	0.00	10.10
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	29.09	2.53	0.84	0.84	0.84	0.42	0.00	14.76
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	23.15	1.36	0.00	0.00	1.36	0.00	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	13.99	0.64	0.00	1.91	0.00	0.00	0.64	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	1.62	0.81	0.81	0.00	0.00	0.00	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	1.51	1.51	1.51	0.00	0.00	0.00	12.08
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	17.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	9.79	0.00	3.26	0.00	0.00	0.00	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	0.00	0.00	0.00	0.00	0.00	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	12.55	12.55	12.55	12.55	0.00	0.00	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	45.03	8.19	1.94	0.43	0.65	0.65	0.65	12.71
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	40.24	6.27	0.00	0.00	0.52	0.52	0.52	19.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	2.00	0.00	1.33	0.67	0.00	0.00	8.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	22.12	3.76	0.42	1.25	0.00	0.00	0.00	7.10
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	41.26	4.18	2.85	1.71	0.19	0.19	0.38	12.93
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	47.88	9.58	0.00	0.00	0.00	0.00	0.00	11.17
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	23.12	4.08	0.00	0.68	0.00	0.00	0.00	2.72
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	1.84	5.51	3.68	1.84	1.84	0.00	53.29
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.04	4.60	1.26	0.42	1.67	0.84	0.00	6.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.29	4.65	1.39	1.86	0.00	0.23	0.46	4.88
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	30.54	6.49	2.97	1.08	0.00	0.27	0.27	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.21	6.31	3.78	1.68	0.42	0.42	0.00	14.93
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	22.27	11.13	0.00	0.00	0.00	0.00	144.75
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.75	7.45	3.97	1.49	1.99	0.50	0.50	4.96
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	30.32	4.87	2.17	1.62	0.00	0.27	0.00	8.93
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	34.23	6.80	2.72	0.91	0.45	0.23	0.68	4.76
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.52	5.23	2.45	1.31	0.33	0.65	0.65	3.76
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	30.80	4.37	3.83	0.55	0.55	0.55	0.73	12.39
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	34.48	5.30	3.71	2.65	1.06	1.06	1.06	6.90
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	25.81	1.80	3.60	3.60	2.40	0.00	0.00	3.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	34.46	3.61	4.92	1.97	0.66	0.33	0.66	20.35
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	31.06	5.53	2.76	0.65	0.65	0.65	0.16	3.25
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	30.51	5.29	2.82	0.71	0.53	0.18	0.35	13.05
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.80	9.14	4.92	2.11	1.41	0.70	0.00	8.44
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	39.08	6.44	6.44	0.92	0.46	0.92	0.00	11.95
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	33.10	5.46	3.21	1.29	0.32	0.96	0.32	4.50
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	44.15	5.52	8.97	2.41	1.03	0.34	0.00	25.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	53.10	2.53	10.11	0.00	0.00	0.00	5.06	48.04
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	36.09	3.79	1.78	0.22	0.00	0.00	0.22	12.48
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.99	3.81	2.54	1.69	0.00	0.00	0.42	9.31
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	40.11	6.41	4.75	0.95	0.00	0.24	1.19	7.12
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	33.48	4.29	4.72	1.29	0.00	0.43	1.29	4.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	9.03	0.00	0.00	0.00	0.00	180.56
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	22.33	2.33	2.00	1.67	0.00	0.00	0.67	4.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.33	4.51	3.61	0.90	0.45	0.45	0.00	11.72
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.97	6.35	3.17	1.19	0.40	0.79	0.00	4.36
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	29.72	4.64	6.50	1.86	0.00	0.00	1.86	7.43
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	35.19	5.30	2.65	3.41	0.00	0.38	0.76	4.54
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.44	5.21	1.63	0.00	0.33	0.00	0.00	7.17
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.43	3.92	0.87	0.00	0.00	0.44	0.00	6.10
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	29.85	5.43	2.26	0.45	0.90	0.00	0.45	17.64
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	6.17	1.76	1.76	0.88	0.00	0.88	4.41
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	30.58	5.32	5.32	0.00	1.99	0.00	0.00	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.28	4.96	0.99	1.49	1.49	0.50	0.00	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.82	5.36	1.53	0.38	0.38	1.15	0.38	7.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.90	4.84	0.91	1.81	0.30	0.00	0.60	3.93
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.04	5.75	3.32	1.33	0.22	0.22	0.00	11.94
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.07	5.42	2.71	0.68	0.00	0.68	0.00	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	5.11	5.11	5.11	5.11	0.00	5.11	61.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	28.66	4.88	1.83	1.22	0.61	0.00	0.00	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.98	2.52	1.26	0.63	0.63	0.00	0.00	5.98
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	29.36	3.33	2.12	0.00	0.61	0.00	0.00	9.08
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	27.69	3.16	0.79	1.58	0.00	0.00	0.00	7.12
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	3.40	2.27	5.67	0.00	0.00	0.00	39.68
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	15.17	15.17	20.23	0.00	0.00	0.00	40.46
Myoblast, donor1	11241-116D8	45.22	8.45	3.85	1.24	0.75	1.24	0.99	18.88
Myoblast, donor2	11322-117D8	50.44	9.40	2.69	1.73	0.38	0.38	0.58	18.60
Myoblast, donor3	11398-118D3	43.55	9.25	3.03	2.35	0.00	0.67	1.18	9.92
NK T cell leukemia cell line:KHYG-1	10777-110G3	26.27	7.44	0.00	0.15	0.00	1.90	1.02	10.07
Natural Killer Cells, donor1	11230-116C6	41.51	20.60	0.92	0.62	0.62	1.23	1.54	12.30
Natural Killer Cells, donor2	11311-117C6	42.22	17.19	1.51	0.60	0.30	1.81	1.21	6.63
Natural Killer Cells, donor3	11387-118C1	41.41	14.54	1.10	1.47	1.29	2.21	1.66	9.39
Neural stem cells, donor1	11275-116H6	90.73	18.15	20.32	2.54	0.73	2.90	1.09	16.33
Neural stem cells, donor2	11352-117H2	82.80	19.26	9.63	1.93	1.93	0.00	5.78	5.78
Neurons, donor1	11494-119E9	67.14	17.07	2.28	2.28	0.00	0.00	1.14	27.31
Neurons, donor2	11574-120E8	62.09	12.55	4.40	2.20	0.22	1.98	1.98	27.08
Neurons, donor3	11655-122E8	47.69	7.40	4.11	1.64	0.00	0.82	1.64	25.49
Neutrophils, donor1	11233-116C9	128.99	56.61	0.00	0.93	0.00	0.00	2.78	8.35
Neutrophils, donor2	11314-117C9	52.18	40.58	0.00	0.00	2.90	0.00	0.00	14.49
Neutrophils, donor3	11390-118C4	188.75	60.47	1.83	3.05	0.61	3.05	4.89	9.16
Nucleus Pulposus Cell, donor1	11252-116F1	71.36	11.04	2.37	0.95	0.12	1.19	0.12	24.34
Nucleus Pulposus Cell, donor2	11409-118E5	30.93	3.26	2.60	0.00	0.00	0.33	0.00	19.21
Nucleus Pulposus Cell, donor3	11462-119B4	32.69	5.82	1.00	0.40	0.20	0.20	0.20	12.03
Olfactory epithelial cells, donor1	11933-125I7	31.52	3.44	0.55	0.28	0.28	0.00	0.28	12.80
Olfactory epithelial cells, donor2	11934-125I8	43.28	4.63	1.16	0.87	0.29	0.87	0.29	19.97
Olfactory epithelial cells, donor3	11935-125I9	34.28	4.99	0.57	0.11	0.23	0.68	0.23	16.80
Olfactory epithelial cells, donor4	11936-126A1	40.61	4.09	0.68	0.78	0.39	0.19	0.19	11.69
Oligodendrocyte - precursors, donor1	11496-119F2	40.92	7.22	3.01	0.60	0.60	0.00	0.00	21.67
Osteoblast - differentiated, donor1	11276-116H7	36.80	4.25	1.91	0.64	1.70	0.43	0.21	5.74
Osteoblast - differentiated, donor2	11353-117H3	24.01	5.72	2.29	0.00	2.29	1.14	1.14	5.72
Osteoblast - differentiated, donor3	11425-118G3	22.35	4.34	1.24	0.00	0.00	0.62	0.00	2.48
Osteoblast, donor1	11277-116H8	29.90	5.86	1.56	0.98	0.20	0.78	0.78	6.64
Osteoblast, donor2	11354-117H4	47.76	19.66	7.02	4.92	0.70	2.81	2.11	16.86
Osteoblast, donor3	11426-118G4	56.87	10.31	2.13	1.07	0.71	0.53	0.89	5.69
Pancreatic stromal cells, donor1	11249-116E7	65.11	8.76	2.61	1.52	0.34	0.59	0.59	25.10
Pericytes, donor1	11491-119E6	9.12	2.56	0.22	0.00	0.11	0.00	0.11	2.89
Pericytes, donor2	11571-120E5	12.68	2.72	0.00	0.23	0.00	0.00	0.00	3.17
Pericytes, donor3	11652-122E5	28.69	4.68	1.83	1.02	0.00	0.20	0.00	8.95
Perineurial Cells, donor1	11499-119F5	50.41	6.78	4.29	1.70	0.11	0.90	0.34	17.41
Perineurial Cells, donor2	11579-120F4	68.55	9.20	2.67	1.56	0.28	0.37	0.37	4.23
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	61.52	13.71	2.55	2.23	0.00	1.27	1.91	16.26
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	38.69	7.10	3.67	3.18	0.73	0.73	0.49	11.51
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	42.45	10.87	2.07	1.42	0.00	0.39	0.91	4.92
Placental Epithelial Cells, donor1	11278-116H9	22.96	6.22	0.00	0.48	0.00	0.24	0.48	5.74
Placental Epithelial Cells, donor2	11355-117H5	15.52	2.22	0.00	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	16.30	3.53	0.59	0.39	0.00	0.39	0.20	3.53
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	24.05	2.85	1.90	0.95	0.32	0.32	0.00	6.01
Preadipocyte - breast, donor1	11467-119B9	45.58	7.32	5.44	1.50	0.38	1.50	0.56	17.82
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	62.78	9.92	1.17	1.04	0.13	0.65	1.31	12.79
Preadipocyte - breast, donor2	11328-117E5	39.63	6.08	1.13	0.45	0.45	0.45	0.45	16.21
Preadipocyte - omental, donor1	11468-119C1	56.58	9.80	5.11	3.20	0.21	1.17	0.32	24.83
Preadipocyte - omental, donor2	11329-117E6	36.66	7.86	3.93	0.87	0.00	0.87	0.00	20.08
Preadipocyte - omental, donor3	11403-118D8	44.84	9.31	2.29	1.58	0.72	0.43	0.29	15.33
Preadipocyte - perirenal, donor1	11469-119C2	14.76	2.95	1.97	0.98	0.98	0.00	0.00	6.89
Preadipocyte - subcutaneous, donor1	11279-116I1	23.03	6.14	0.31	0.31	0.00	0.00	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	55.78	12.93	2.83	1.59	0.35	1.24	0.53	22.31
Preadipocyte - subcutaneous, donor3	11428-118G6	42.74	8.17	2.21	1.53	0.17	0.51	0.00	11.41
Preadipocyte - visceral, donor1	11280-116I2	62.41	8.38	4.56	1.96	0.75	0.65	0.65	26.45
Preadipocyte - visceral, donor2	11357-117H7	44.18	7.36	2.30	2.30	0.46	0.46	0.46	18.41
Preadipocyte - visceral, donor3	11429-118G7	35.32	7.42	2.72	1.88	0.00	0.73	0.31	13.48
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.51	4.22	0.30	0.00	0.45	0.15	0.75	21.27
Prostate Epithelial Cells, donor2	11331-117E8	56.33	9.89	2.44	1.90	0.81	0.54	0.54	22.34
Prostate Epithelial Cells, donor3	11404-118D9	73.61	8.51	0.80	1.53	0.67	0.86	0.73	28.78
Prostate Stromal Cells, donor1	11254-116F3	46.70	7.40	4.21	1.14	0.34	1.37	0.34	18.22
Prostate Stromal Cells, donor2	11332-117E9	54.69	11.83	3.05	1.26	0.54	0.54	0.36	27.07
Prostate Stromal Cells, donor3	11405-118E1	38.89	7.09	2.19	0.94	0.42	0.31	0.42	14.91
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.87	3.65	0.36	0.00	0.00	0.00	0.00	9.12
Renal Cortical Epithelial Cells, donor2	11596-120H3	48.52	7.69	0.90	1.39	0.07	0.69	0.62	19.75
Renal Epithelial Cells, donor1	11517-119H5	16.23	1.52	0.00	0.00	0.00	0.00	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	10.67	4.27	0.71	0.00	0.00	0.00	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	58.23	6.78	2.22	1.16	0.00	0.32	0.32	21.70
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.89	2.72	0.00	0.00	0.00	0.00	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	22.78	2.96	0.40	1.21	0.27	0.13	0.00	6.60
Renal Glomerular Endothelial Cells, donor3	11675-122H1	44.40	6.44	0.89	0.89	0.00	0.44	0.22	13.32
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	20.69	3.96	0.22	0.22	0.00	0.44	0.22	6.16
Renal Mesangial Cells, donor2	11598-120H5	21.94	5.64	1.25	0.63	0.00	0.63	0.00	10.66
Renal Mesangial Cells, donor3	11679-122H5	4.99	3.05	0.00	0.55	0.00	0.28	0.00	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	37.04	7.52	1.07	0.54	0.27	0.27	0.00	18.79
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.24	2.95	0.84	0.00	0.42	0.00	0.42	5.90
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	24.88	3.86	0.77	0.39	0.00	0.77	0.00	5.79
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.93	4.93	0.00	0.26	0.26	0.26	0.26	14.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.74	3.98	0.28	0.00	0.00	0.57	0.57	8.81
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	1.03	0.00	0.00	0.00	0.00	0.00	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	39.14	6.77	0.75	1.00	0.25	0.00	0.25	23.33
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	46.51	5.61	0.13	1.07	0.40	0.13	0.40	28.33
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	22.34	6.25	1.79	0.00	0.00	0.00	0.00	12.51
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	39.63	6.60	2.20	0.55	0.55	0.00	0.55	11.01
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.22	2.32	0.58	0.00	0.00	0.00	0.58	5.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.77	3.64	0.78	0.13	0.13	0.26	0.26	9.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.73	3.87	0.79	0.00	0.30	0.50	0.70	8.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.01	5.02	0.45	0.56	0.45	0.89	0.89	12.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	36.22	5.46	1.86	0.37	0.25	0.25	0.87	11.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	24.12	4.31	0.58	0.35	0.00	0.47	0.58	10.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.43	3.47	0.46	0.23	0.00	0.69	0.46	9.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	16.16	3.42	0.55	0.14	0.14	0.27	0.55	8.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.35	2.12	1.51	0.30	0.91	0.15	0.76	7.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	27.42	3.58	0.36	0.36	0.18	0.00	0.18	5.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.67	4.73	0.14	0.14	0.43	0.14	0.43	8.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	28.33	4.29	0.64	0.54	0.11	0.75	0.86	10.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.68	3.32	0.66	0.44	0.44	0.00	0.66	9.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.87	4.40	0.96	0.00	0.19	0.00	0.19	7.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.10	4.01	0.65	0.09	0.09	0.28	0.56	6.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	34.57	3.01	1.50	0.56	0.38	0.19	0.56	15.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.19	2.92	0.40	0.00	0.13	0.27	0.27	8.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.89	3.89	1.27	0.39	0.39	0.10	0.29	6.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.44	3.44	0.38	0.00	0.19	0.38	0.38	8.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.41	3.42	0.64	0.00	0.32	0.21	0.32	7.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	24.95	3.64	0.28	0.28	0.56	0.00	0.28	8.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	28.71	3.42	0.68	0.34	0.17	0.34	0.34	8.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	16.77	4.01	0.73	0.18	0.00	0.18	0.00	8.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.98	4.05	1.10	0.37	0.12	0.49	0.37	7.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.54	3.76	0.54	0.13	0.40	0.54	0.27	9.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.15	4.48	1.42	0.00	0.24	0.24	0.71	11.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.58	2.38	1.98	0.00	0.20	0.20	0.40	4.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.00	3.51	1.17	0.00	0.23	0.23	0.70	9.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	19.70	3.73	1.45	0.00	0.21	0.41	1.04	6.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.78	3.98	1.11	0.22	0.44	0.00	1.11	9.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.31	5.43	0.84	0.21	0.21	0.21	0.84	6.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.21	4.44	1.48	0.13	0.13	0.27	0.54	9.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.07	3.58	0.34	0.00	0.51	0.17	0.34	6.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	23.33	5.21	0.77	0.00	0.39	1.54	0.58	5.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	16.51	6.36	2.41	0.34	0.00	0.52	0.69	7.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	26.47	4.25	0.82	0.41	0.27	0.14	0.41	6.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	28.57	4.43	2.13	0.82	0.49	0.49	0.82	7.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	15.85	3.41	0.85	0.34	0.34	0.17	0.00	4.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.56	4.59	2.66	0.59	0.00	0.59	0.44	11.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	20.52	3.20	0.80	0.00	0.00	0.80	0.00	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.98	4.15	0.55	0.14	0.28	0.28	0.41	5.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	20.95	3.33	0.24	0.00	0.24	0.24	0.48	13.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	30.63	2.82	0.20	0.60	0.20	0.20	0.40	9.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.10	3.30	0.47	0.19	0.38	0.47	0.09	6.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	36.68	6.99	1.05	0.70	0.00	0.00	1.05	13.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.06	3.32	1.21	0.30	0.00	0.00	0.60	8.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.26	2.94	1.22	0.49	0.37	0.12	0.37	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.91	6.11	1.60	0.58	0.00	0.44	0.44	12.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	32.86	3.04	0.61	0.00	1.22	0.00	0.61	15.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.06	2.71	1.51	0.60	0.30	0.00	0.00	7.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	28.73	4.30	1.36	0.23	0.68	0.23	0.00	13.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.84	3.29	0.60	0.30	0.30	0.30	0.60	11.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.08	4.49	1.53	0.12	0.24	0.00	0.00	9.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	37.78	5.55	1.49	0.43	2.77	0.21	0.85	5.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.29	6.01	1.20	0.60	1.20	0.60	0.60	4.81
Schwann Cells, donor1	11498-119F4	12.60	3.01	0.00	0.19	0.38	0.38	0.38	3.01
Schwann Cells, donor2	11578-120F3	20.41	3.40	0.00	3.40	0.00	0.00	0.00	13.61
Schwann Cells, donor3	11659-122F3	28.48	8.54	2.63	0.44	0.44	0.22	0.66	23.22
Sebocyte, donor1	11220-116B5	82.71	12.05	1.10	1.10	0.00	1.64	0.00	27.39
Sebocyte, donor2	11301-117B5	42.74	8.27	1.38	1.38	0.46	0.92	0.46	11.95
Sebocyte, donor3	11378-118B1	36.07	6.39	0.82	0.62	0.00	0.21	0.00	8.86
Sertoli Cells, donor1	11255-116F4	56.32	4.97	11.60	1.66	0.00	1.66	1.66	31.48
Sertoli Cells, donor2	11333-117F1	56.49	5.65	11.30	11.30	0.00	0.00	0.00	53.66
Skeletal Muscle Cells, donor1	11281-116I3	49.53	5.72	1.41	1.41	0.26	0.44	0.70	20.76
Skeletal Muscle Cells, donor2	11358-117H8	18.07	1.45	0.72	0.00	0.00	0.00	0.72	1.45
Skeletal Muscle Cells, donor3	11430-118G8	25.92	5.02	0.00	0.00	0.00	0.00	0.84	5.85
Skeletal Muscle Cells, donor4	11451-119A2	32.83	5.66	1.10	1.26	0.16	0.31	0.79	10.37
Skeletal Muscle Cells, donor5	11455-119A6	31.51	7.73	1.34	0.45	0.45	0.30	0.45	11.15
Skeletal Muscle Cells, donor6	11459-119B1	37.71	6.16	0.92	0.77	0.31	0.31	0.46	8.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	60.10	9.20	3.40	3.15	0.13	1.01	0.38	21.04
Skeletal Muscle Satellite Cells, donor2	11321-117D7	50.51	9.27	1.57	1.71	0.14	1.00	0.29	15.84
Skeletal Muscle Satellite Cells, donor3	11397-118D2	41.87	9.52	1.79	0.99	0.00	1.09	0.69	8.53
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	51.81	6.15	2.27	1.01	0.34	0.76	0.51	21.57
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	34.74	7.24	0.00	0.00	0.72	0.00	0.00	12.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	25.73	5.92	0.83	0.83	0.55	0.14	0.28	4.40
Skin - palm, donor1	10286-104F7	80.58	21.49	0.00	0.00	2.69	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	31.86	10.38	1.01	1.01	0.72	0.29	0.58	8.07
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	103.05	35.99	7.36	4.09	0.00	0.00	0.00	20.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	37.00	8.96	0.91	1.17	0.78	0.52	0.13	7.92
Small Airway Epithelial Cells, donor1	11256-116F5	114.68	16.12	4.73	3.48	1.95	0.70	1.11	46.29
Small Airway Epithelial Cells, donor2	11334-117F2	64.14	11.82	2.39	2.39	0.84	0.56	0.28	24.19
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	175.71	34.25	3.38	6.77	0.85	2.33	2.54	18.82
Small Airway Epithelial Cells, donor3	11406-118E2	99.01	13.12	0.82	1.95	0.75	1.20	1.20	20.09
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	32.40	14.50	6.79	2.78	0.93	1.85	0.00	14.19
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	40.02	12.45	3.56	0.89	0.22	0.22	0.67	7.34
Smooth Muscle Cells - Aortic, donor0	11210-116A4	39.97	5.29	0.59	2.94	0.00	0.00	0.59	7.05
Smooth Muscle Cells - Aortic, donor1	11283-116I5	49.06	5.08	1.99	1.33	0.44	0.22	0.22	8.18
Smooth Muscle Cells - Aortic, donor2	11360-117I1	30.71	9.45	1.97	1.18	1.18	0.00	0.39	9.84
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.08	8.50	1.55	2.32	0.00	0.00	0.00	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	48.04	4.00	1.00	1.00	0.00	0.00	0.00	30.02
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	35.00	5.46	2.66	1.73	0.27	0.93	0.53	4.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.67	6.87	7.09	3.32	0.22	1.11	1.11	20.61
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	74.64	13.96	6.91	2.30	2.82	0.26	1.41	10.75
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	36.47	5.54	1.30	0.33	0.00	1.63	0.33	10.74
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.46	6.50	1.48	0.59	0.30	0.89	0.00	11.22
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	39.58	7.40	1.28	0.43	0.28	0.28	0.00	5.98
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	16.59	3.74	0.49	0.16	0.16	0.16	0.16	4.39
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	48.71	7.00	1.22	0.61	0.61	0.91	0.91	16.44
Smooth Muscle Cells - Carotid, donor1	11285-116I7	33.84	4.80	2.27	1.01	0.51	0.51	0.51	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	0.00	0.00	0.00	0.00	0.00	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.93	3.81	1.43	0.00	0.48	0.00	0.48	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.11	6.19	1.03	1.18	0.15	0.74	0.44	16.81
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.35	4.09	1.51	0.86	0.43	0.22	0.22	11.19
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.36	6.51	1.36	0.21	0.00	0.42	0.31	7.87
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.33	6.19	1.55	0.93	2.01	0.77	0.93	6.50
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	36.65	2.16	6.47	0.00	0.00	1.08	1.08	8.62
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	29.59	5.68	1.79	0.90	0.60	0.30	0.30	7.17
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.90	0.68	0.00	0.00	0.00	0.34	0.00	3.07
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	67.54	8.48	2.12	0.94	0.00	0.31	0.71	25.21
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	74.98	11.98	6.94	2.42	1.61	0.70	0.40	24.46
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	58.71	8.87	7.51	3.64	0.68	0.46	0.00	32.77
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	3.62	1.81	2.42	0.00	0.00	0.00	8.45
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	48.48	6.36	2.65	1.85	0.53	1.06	0.79	7.68
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.88	7.99	2.40	1.33	0.40	0.27	0.93	17.44
Smooth Muscle Cells - Prostate, donor2	11335-117F3	57.48	9.89	1.88	1.88	0.38	0.13	0.13	18.28
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.81	7.10	2.28	0.76	0.51	0.25	0.25	6.34
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	52.62	9.80	4.98	4.22	0.45	0.60	0.45	14.17
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	9.75	1.50	0.75	0.00	0.75	0.75	6.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	81.41	1.29	0.00	1.29	2.58	2.58	2.58	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.74	4.19	1.40	0.93	0.00	0.00	0.00	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	42.41	5.55	7.57	2.02	0.00	0.00	0.50	18.68
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	47.01	7.21	8.15	4.07	0.94	0.00	0.31	9.40
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.52	4.42	0.59	0.00	0.00	0.29	0.29	6.78
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	52.65	7.58	2.92	1.92	0.33	0.58	0.17	18.99
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	35.97	7.94	2.34	0.93	0.00	0.93	0.93	16.82
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	29.65	4.03	1.87	1.44	0.86	0.29	0.72	4.75
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.73	3.57	1.02	2.29	0.51	0.25	0.00	6.88
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.73	5.64	1.50	0.56	0.19	0.00	0.00	4.70
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	52.12	9.08	1.82	1.40	0.14	0.56	0.70	17.05
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	52.03	7.88	3.02	1.84	0.00	0.59	0.50	16.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	0.95	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	24.71	4.16	1.22	1.47	0.73	0.00	0.49	6.85
Smooth Muscle Cells - Uterine, donor1	11258-116F7	43.53	10.83	3.09	1.10	0.00	0.44	0.66	15.02
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.06	5.56	0.88	2.34	0.00	0.59	0.59	7.31
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.59	4.86	2.14	0.58	0.19	0.00	0.19	6.61
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.62	4.23	2.12	0.79	1.32	0.79	0.26	11.90
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	53.56	7.81	7.44	0.37	0.37	0.00	0.00	27.52
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	70.43	11.86	6.47	1.08	1.08	0.72	0.72	13.65
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	45.42	5.11	2.27	1.14	0.00	0.57	0.57	5.96
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.02	6.70	0.39	1.58	0.00	0.00	0.39	18.51
Smooth muscle cells - airway, control, donor1	11966-126D4	35.55	8.38	2.79	1.52	1.52	0.00	0.25	15.24
Smooth muscle cells - airway, control, donor2	11967-126D5	54.71	7.99	0.80	0.40	1.60	0.40	0.00	15.17
Smooth muscle cells - airway, control, donor3	11968-126D6	32.19	4.18	2.09	0.84	1.25	0.84	0.42	25.08
Smooth muscle cells - airway, control, donor4	11969-126D7	39.42	5.96	0.92	0.46	0.00	0.00	1.83	17.42
Synoviocyte, donor1	11291-117A4	53.02	8.25	2.86	1.35	0.34	0.50	0.34	24.41
Synoviocyte, donor2	11368-117I9	34.36	4.86	5.36	1.01	0.50	0.00	0.17	16.76
Synoviocyte, donor3	11440-118H9	27.48	5.14	3.13	0.22	0.67	0.22	0.00	10.05
Trabecular Meshwork Cells, donor1	11532-120A2	12.51	2.86	0.00	0.00	0.36	0.00	0.00	2.50
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	1.98	0.00	0.00	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	18.06	1.16	0.23	0.23	0.00	0.46	0.00	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	73.69	12.19	0.86	0.93	1.08	0.22	0.65	39.28
Tracheal Epithelial Cells, donor2	11369-118A1	23.97	3.48	0.39	0.00	0.00	0.00	0.39	4.25
Tracheal Epithelial Cells, donor3	11441-118I1	33.21	5.73	0.00	0.00	0.57	0.57	0.00	4.01
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	53.27	6.64	0.98	0.74	0.37	0.49	0.62	24.60
Urethra, donor2	10319-105A4	32.37	7.19	1.80	1.80	0.00	0.00	3.60	10.79
Urothelial Cells, donor1	11520-119H8	39.32	6.91	0.00	0.00	0.00	0.00	0.53	12.49
Urothelial Cells, donor2	11600-120H7	28.04	5.61	0.40	0.00	0.40	0.80	0.00	16.42
Urothelial Cells, donor3	11681-122H7	31.17	4.35	0.00	0.23	0.23	0.23	0.00	7.33
Urothelial cells, donor0	11216-116B1	105.88	10.92	0.67	0.22	0.45	0.67	0.67	38.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	67.62	25.80	0.89	1.78	0.00	0.89	0.00	16.91
Whole blood (ribopure), donor090309, donation2	12180-129A2	65.76	24.30	2.86	0.00	1.43	0.00	2.86	8.58
Whole blood (ribopure), donor090309, donation3	12181-129A3	37.65	8.90	0.00	1.37	0.68	1.37	0.68	15.06
Whole blood (ribopure), donor090325, donation1	12176-128I7	51.31	12.40	0.69	0.34	0.00	1.38	1.03	17.91
Whole blood (ribopure), donor090325, donation2	12177-128I8	58.10	12.78	0.58	1.16	0.00	0.00	0.00	17.43
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	16.66	1.04	1.04	0.00	0.00	2.08	13.54
Whole blood (ribopure), donor090612, donation2	12183-129A5	45.89	21.11	0.92	0.00	0.92	1.84	1.84	22.94
Whole blood (ribopure), donor090612, donation3	12184-129A6	43.82	5.48	0.00	1.83	0.00	1.83	0.00	20.08
Wilms' tumor cell line:G-401	10809-111A8	32.32	4.69	0.74	0.00	0.00	0.25	0.25	14.68
Wilms' tumor cell line:HFWT	10597-108E3	21.12	3.52	0.00	0.00	0.00	0.00	0.00	5.28
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	42.46	5.31	0.00	0.00	0.00	0.28	0.28	10.89
achilles tendon, donor2	10292-104G4	57.86	8.27	6.20	0.00	2.07	0.00	0.00	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	24.48	7.65	0.00	0.00	0.00	0.76	1.02	6.88
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.23	2.32	0.00	0.00	0.00	0.23	0.23	3.48
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	45.23	6.89	0.12	0.12	0.00	0.36	0.95	10.80
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	57.14	10.34	0.00	0.27	0.27	0.54	0.54	18.78
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.30	1.12	0.00	0.00	0.00	0.00	0.00	7.59
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.94	2.54	0.63	0.63	0.00	0.63	0.00	2.54
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	39.20	6.53	1.63	4.08	0.27	0.00	0.27	16.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	39.66	3.08	0.88	0.44	0.44	0.44	0.88	15.86
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	37.16	4.49	0.41	0.00	0.00	0.41	0.00	15.52
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	27.18	3.88	0.39	0.00	0.39	0.39	0.39	13.20
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.98	6.44	0.55	0.18	0.18	0.55	0.37	16.56
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	0.00	0.00	0.00	0.00	0.00	3.90	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	45.08	5.81	0.23	0.23	0.93	0.00	0.70	13.71
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.93	5.70	2.33	4.14	0.00	0.26	0.26	20.71
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	37.70	4.09	0.58	2.34	1.17	0.29	0.29	14.61
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	37.18	7.44	0.93	1.39	0.46	0.46	0.00	7.90
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.44	2.88	0.00	0.00	0.00	0.00	0.00	12.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	55.25	4.91	1.23	0.61	0.92	0.92	0.31	4.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	59.74	5.97	4.69	2.99	0.43	0.43	0.43	8.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.09	6.67	3.64	3.94	0.30	0.00	0.30	12.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	73.17	6.50	4.09	2.65	0.00	0.24	1.44	13.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	28.51	4.45	0.00	0.00	0.22	0.67	0.22	10.69
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	33.02	6.00	0.33	0.00	0.00	0.00	1.00	8.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	1.86	0.00	0.00	0.00	0.00	0.00	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	49.34	8.66	0.00	0.00	0.75	0.00	0.38	15.44
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	43.61	4.36	0.44	0.00	0.44	0.00	0.00	13.08
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	5.62	0.00	0.00	0.00	0.00	0.00	13.12
adenocarcinoma cell line:IM95m	10796-110I4	37.68	6.83	0.00	0.24	0.47	0.24	0.71	5.18
adipose tissue, adult, pool1	10010-101C1	47.93	3.10	0.93	1.55	0.16	0.16	0.31	9.46
adipose, donor1	10184-103D4	66.26	8.80	3.52	0.00	0.59	0.00	2.35	75.06
adipose, donor2	10185-103D5	54.34	12.17	1.62	0.41	0.41	0.00	0.41	32.44
adipose, donor3	10186-103D6	48.20	9.26	2.18	0.54	0.82	1.09	1.09	25.32
adipose, donor4	10187-103D7	117.88	6.07	0.87	0.00	0.00	0.87	0.00	27.74
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	39.14	6.47	0.00	0.00	0.00	0.47	0.32	7.42
adrenal gland, adult, pool1	10081-102A9	18.19	10.91	7.28	3.64	0.00	3.64	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	58.97	8.54	0.27	1.20	0.40	0.93	1.33	13.74
alveolar cell carcinoma cell line:SW 1573	10708-109H6	81.11	7.15	1.79	0.36	1.07	0.71	0.71	50.02
amniotic membrane cells, donor1	12235-129G3	85.09	19.94	2.78	2.55	0.70	1.39	2.09	13.68
amniotic membrane cells, donor2	12236-129G4	53.76	7.78	1.01	0.34	0.00	3.38	0.68	8.11
amniotic membrane cells, donor3	12237-129G5	84.26	19.44	2.95	1.47	1.18	1.77	1.47	18.27
amygdala - adult, donor10196	10167-103B5	45.06	10.67	5.93	2.37	1.19	1.19	0.00	10.67
amygdala, adult, donor10252	10151-102I7	50.89	10.14	2.03	2.03	0.81	0.61	0.41	16.02
amygdala, newborn, donor10223	10360-105E9	36.47	14.20	9.04	2.90	0.65	1.94	0.97	14.20
anaplastic carcinoma cell line:8305C	10428-106D5	81.62	6.37	0.64	0.64	0.38	0.25	0.89	26.10
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	57.80	12.58	2.87	5.29	1.10	1.76	2.43	21.62
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	53.45	7.35	1.34	0.33	0.67	0.67	0.33	21.38
aorta, adult, pool1	10052-101G7	56.09	7.06	2.35	2.75	0.39	0.39	0.98	8.43
appendix, adult	10189-103D9	46.96	11.64	2.33	0.78	1.55	3.10	0.39	10.48
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	35.77	4.82	0.00	0.00	0.00	0.34	0.00	25.45
artery, adult	10190-103E1	35.33	8.15	0.00	0.00	1.36	0.00	0.00	16.30
astrocytoma cell line:TM-31	10425-106D2	24.63	3.19	0.14	1.01	0.43	0.29	0.58	19.70
b cell line:RPMI1788	10427-106D4	61.86	8.92	0.00	0.30	0.00	0.74	0.30	12.64
basal cell carcinoma cell line:TE 354.T	10702-109G9	50.22	5.55	2.77	1.66	0.28	0.55	0.28	14.15
bile duct carcinoma cell line:HuCCT1	10432-106D9	73.23	11.31	0.30	0.89	0.20	0.99	1.19	19.85
bile duct carcinoma cell line:TFK-1	10496-107C1	41.51	3.18	1.00	0.33	0.17	0.33	0.67	31.30
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	52.57	4.47	2.24	1.68	1.12	0.56	0.56	19.57
bladder, adult, pool1	10011-101C2	69.96	5.98	2.50	1.30	0.22	0.54	0.65	13.15
blood, adult, pool1	10053-101G8	46.51	13.29	0.00	0.00	0.00	2.21	0.00	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	33.40	5.14	3.43	0.00	0.00	1.71	0.00	10.28
bone marrow, adult	10192-103E3	39.14	4.72	0.67	0.67	0.00	0.67	0.67	16.87
brain, adult, donor1	10084-102B3	35.88	8.20	2.05	2.05	0.00	0.00	1.03	7.18
brain, adult, pool1	10012-101C3	55.35	9.91	1.00	1.78	0.22	1.22	1.11	8.80
brain, fetal, pool1	10085-102B4	45.41	10.69	0.00	0.00	0.00	0.00	2.67	10.69
breast carcinoma cell line:MCF7	10482-107A5	67.06	17.84	0.00	0.00	1.32	1.32	1.32	22.80
breast carcinoma cell line:MDA-MB-453	10419-106C5	106.97	16.60	0.00	0.00	0.25	1.12	0.75	40.57
breast, adult, donor1	10080-102A8	32.83	5.68	0.00	0.63	0.63	0.00	0.63	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.86	5.97	0.38	0.76	0.51	0.51	0.51	19.94
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.67	10.51	0.31	0.00	0.31	0.62	0.93	25.97
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	91.86	14.27	0.23	0.23	0.23	1.61	0.46	35.45
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	61.25	7.50	0.48	0.00	0.00	1.45	0.00	20.58
carcinoid cell line:NCI-H1770	10703-109H1	25.39	1.88	0.00	0.00	0.00	0.00	0.00	11.75
carcinoid cell line:NCI-H727	10735-110B6	45.61	3.83	0.00	0.00	0.00	0.11	0.98	10.50
carcinoid cell line:SK-PN-DW	10719-109I8	46.58	5.07	0.00	0.00	0.32	0.00	0.32	32.01
carcinosarcoma cell line:JHUCS-1	10642-109A3	54.57	9.58	0.80	1.06	1.60	0.00	0.53	16.50
caudate nucleus - adult, donor10196	10177-103C6	58.72	10.36	4.61	4.61	0.00	0.00	0.00	5.76
caudate nucleus, adult, donor10252	10164-103B2	51.87	9.54	2.68	3.51	0.17	0.50	0.84	12.38
caudate nucleus, adult, donor10258	10379-105H1	32.86	6.88	1.53	3.06	0.76	0.00	3.06	11.46
caudate nucleus, newborn, donor10223	10354-105E3	39.19	6.96	8.42	1.46	0.37	1.46	1.83	9.89
cerebellum - adult, donor10196	10173-103C2	81.57	11.65	14.57	5.83	0.00	5.83	0.00	14.57
cerebellum, adult, donor10252	10166-103B4	69.39	10.68	1.92	0.85	0.85	1.71	1.07	18.15
cerebellum, adult, pool1	10083-102B2	40.36	10.35	5.17	0.69	0.34	0.34	1.38	8.97
cerebellum, newborn, donor10223	10357-105E6	48.99	9.13	16.61	4.98	0.83	1.66	2.49	8.30
cerebral meninges, adult	10188-103D8	49.92	9.08	3.03	1.76	0.25	2.77	2.02	11.60
cerebrospinal fluid, donor2	10294-104G6	21.20	0.73	0.00	0.73	0.00	0.00	0.00	6.58
cervical cancer cell line:D98-AH2	10552-107I3	80.09	11.50	0.43	1.73	0.00	1.29	1.44	24.44
cervical cancer cell line:ME-180	10553-107I4	236.81	25.52	2.15	0.99	0.33	1.66	2.65	85.68
cervix, adult, pool1	10013-101C4	65.93	9.45	1.99	0.73	0.73	0.84	1.05	22.57
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	69.53	8.36	0.84	0.70	0.28	0.84	0.84	20.62
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	1.31	0.00	0.00	0.00	0.00	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	74.32	8.95	0.37	0.25	1.24	0.99	1.49	18.27
choriocarcinoma cell line:SCH	10785-110H2	40.29	5.30	0.12	0.25	0.25	0.49	0.49	19.96
choriocarcinoma cell line:T3M-3	10618-108G6	64.28	9.72	0.24	0.24	0.47	0.47	0.95	27.04
chorionic membrane cells, donor1	12238-129G6	62.97	10.54	1.42	1.42	0.28	0.85	1.99	8.55
chorionic membrane cells, donor2	12239-129G7	60.55	8.15	1.59	0.60	0.50	0.70	0.89	15.01
chorionic membrane cells, donor3	12240-129G8	51.10	7.69	2.75	2.20	1.10	1.10	1.10	15.94
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	32.31	6.06	0.00	0.00	0.00	0.00	1.01	20.20
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	28.05	3.46	0.58	0.77	0.19	0.77	0.58	11.53
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.29	4.43	0.00	0.21	0.42	0.63	0.00	5.07
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	40.32	6.93	0.00	0.00	0.26	0.77	0.51	9.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.78	5.81	0.24	0.00	0.48	0.97	0.48	11.37
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	47.03	5.70	0.00	0.00	0.41	0.20	1.22	9.57
chronic myelogenous leukemia cell line:K562	10454-106G4	35.63	5.30	0.00	0.00	0.00	0.29	0.29	12.96
chronic myelogenous leukemia cell line:KU812	10409-106B4	35.45	7.30	0.26	0.00	0.26	0.26	0.00	11.73
clear cell carcinoma cell line:JHOC-5	10638-108I8	33.37	4.34	0.23	0.23	0.23	0.46	0.46	17.14
clear cell carcinoma cell line:TEN	10636-108I6	58.30	5.03	1.21	0.17	0.00	0.35	0.87	17.87
colon carcinoma cell line:CACO-2	10513-107D9	36.61	4.58	0.00	0.18	0.00	0.18	0.55	20.50
colon carcinoma cell line:COLO-320	10420-106C6	38.39	3.04	0.00	0.00	0.00	0.38	0.00	7.98
colon, adult, donor1	10082-102B1	20.23	3.57	0.00	0.00	0.00	0.00	2.38	5.95
colon, adult, pool1	10014-101C5	50.41	7.40	0.59	0.82	0.94	0.24	0.24	20.33
colon, fetal, donor1	10070-101I7	55.00	8.65	3.09	0.62	1.24	1.24	0.62	15.45
common myeloid progenitor CMP, donor1	12130-128D6	82.50	9.17	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	79.89	13.17	6.80	4.67	0.42	0.85	1.70	42.07
cord blood derived cell line:COBL-a 24h infection	10453-106G3	39.85	6.19	3.32	2.87	0.30	0.30	0.60	18.11
cord blood derived cell line:COBL-a untreated	10449-106F8	42.16	6.91	2.96	1.41	0.42	0.28	0.42	16.22
corpus callosum, adult, pool1	10042-101F6	63.68	8.73	1.11	1.44	0.22	1.00	0.77	9.29
cruciate ligament, donor2	10295-104G7	44.58	4.05	0.81	2.43	0.00	0.00	0.00	11.35
diaphragm, fetal, donor1	10069-101I6	28.09	5.62	0.00	0.80	0.00	0.80	0.00	4.82
diencephalon, adult	10193-103E4	35.76	5.52	0.72	0.72	2.40	0.48	0.00	9.84
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	18.83	9.64	0.00	0.00	0.23	0.46	1.15	8.27
ductal cell carcinoma cell line:KLM-1	10438-106E6	114.63	17.18	0.51	0.00	1.28	1.54	0.77	63.60
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	100.38	18.05	2.89	2.17	0.00	0.96	0.72	40.20
ductus deferens, adult	10196-103E7	60.80	16.94	2.49	1.00	1.50	1.50	0.00	17.94
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	1.44	4.32	1.44	0.00	0.00	1.44	10.08
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.97	11.77	0.00	0.00	0.00	0.74	0.74	30.90
dura mater, adult, donor1	10041-101F5	82.17	11.40	6.94	2.81	0.33	0.83	0.74	7.68
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	64.18	13.32	3.78	5.55	1.33	0.89	0.89	13.77
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	47.86	5.59	0.43	0.29	0.14	0.14	0.29	16.48
embryonic pancreas cell line:1B2C6	10604-108F1	24.66	1.85	0.62	0.00	0.00	0.00	0.00	12.95
embryonic pancreas cell line:1C3D3	10605-108F2	31.78	3.94	0.00	0.00	0.61	0.00	0.61	14.53
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.36	4.32	0.00	0.31	0.31	0.31	0.00	8.95
embryonic pancreas cell line:2C6	10603-108E9	23.64	2.63	0.00	0.00	0.00	0.00	0.00	10.51
endometrial carcinoma cell line:OMC-2	10497-107C2	49.94	6.70	3.35	0.67	1.01	1.68	1.01	32.51
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	101.67	10.15	2.54	1.81	0.36	0.54	1.09	34.62
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	44.22	7.08	2.41	0.00	0.32	0.48	0.32	12.22
epidermoid carcinoma cell line:A431	10426-106D3	85.15	10.78	0.56	0.56	0.33	1.45	0.56	34.46
epidermoid carcinoma cell line:Ca Ski	10431-106D8	69.73	7.81	1.21	0.77	0.11	0.88	0.44	23.65
epididymis, adult	10197-103E8	47.30	8.79	1.26	1.26	1.05	0.63	0.42	17.58
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	96.51	19.69	3.02	1.42	1.24	1.60	1.95	36.01
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	43.65	4.72	0.79	0.39	0.79	0.39	0.79	12.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.85	2.62	0.26	0.13	0.13	0.39	0.66	16.51
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	53.54	4.92	0.20	0.30	0.39	0.69	0.69	15.06
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	37.98	4.03	0.34	0.34	0.22	0.45	0.22	12.44
esophagus, adult, pool1	10015-101C6	99.91	12.53	1.17	1.27	0.53	0.85	0.64	19.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	75.27	11.90	20.91	3.01	0.13	1.25	0.75	28.80
eye - muscle inferior rectus, donor1	10272-104E2	72.44	24.15	0.00	0.00	2.41	0.00	2.41	19.32
eye - muscle lateral, donor2	10298-104H1	31.56	2.10	2.10	0.00	2.10	2.10	0.00	16.83
eye - muscle medial, donor2	10299-104H2	25.30	1.49	0.00	1.49	0.00	0.00	0.00	5.95
eye - muscle superior, donor2	10297-104G9	29.81	2.29	1.15	1.15	1.15	0.00	1.15	14.90
eye - vitreous humor, donor1	10268-104D7	64.13	13.12	1.46	0.00	0.00	0.00	0.00	5.83
eye, fetal, donor1	10054-101G9	45.51	4.58	1.27	0.25	0.76	0.76	0.51	13.22
fibrosarcoma cell line:HT-1080	10758-110E2	35.13	5.13	0.77	0.51	0.26	0.38	0.38	12.82
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	82.62	8.31	1.19	2.61	0.24	0.95	0.71	35.38
frontal lobe, adult, pool1	10040-101F4	63.61	16.14	1.88	1.69	0.28	1.13	1.50	8.26
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	64.85	11.71	2.70	1.50	1.20	1.20	1.50	25.22
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	46.72	4.11	0.46	1.19	0.00	0.27	0.27	16.37
gall bladder, adult	10198-103E9	47.08	8.21	1.21	0.97	0.48	0.72	0.24	12.55
gamma delta positive T cells, donor1	11937-126A2	35.43	15.57	0.54	0.00	0.00	2.68	1.61	15.03
gamma delta positive T cells, donor2	11938-126A3	42.20	16.81	0.00	0.00	0.37	1.12	0.75	12.33
gastric adenocarcinoma cell line:MKN1	10614-108G2	96.31	15.84	2.11	0.00	1.27	0.84	1.48	28.94
gastric adenocarcinoma cell line:MKN45	10612-108F9	63.63	6.00	0.00	0.39	0.77	0.58	0.19	17.60
gastric cancer cell line:AZ521	10549-107H9	42.96	6.07	0.49	0.33	0.16	0.98	0.82	20.17
gastric cancer cell line:GSS	10560-108A2	16.47	2.75	0.00	0.00	0.00	0.00	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	24.67	2.06	0.00	0.00	0.00	0.46	0.00	8.22
giant cell carcinoma cell line:LU65	10487-107B1	54.04	6.43	0.69	2.64	0.00	0.23	0.34	22.03
giant cell carcinoma cell line:Lu99B	10433-106E1	88.73	13.72	0.42	0.56	0.28	0.70	0.56	16.94
glassy cell carcinoma cell line:HOKUG	10688-109F4	78.82	8.23	0.75	0.75	1.25	1.00	0.25	34.42
glioblastoma cell line:A172, tech_rep1	10444-106F3	65.02	8.97	1.69	0.53	0.32	1.37	1.06	28.18
glioblastoma cell line:A172, tech_rep2	10444-106F3	64.74	9.83	1.54	1.54	0.28	1.40	0.14	18.96
glioblastoma cell line:T98G	10485-107A8	61.81	6.95	0.22	0.11	0.11	0.66	0.33	26.16
glioma cell line:GI-1	10413-106B8	54.77	4.10	0.29	0.00	0.00	0.88	0.29	9.96
globus pallidus - adult, donor10196	10175-103C4	40.09	8.02	5.10	1.46	1.46	0.00	0.73	5.83
globus pallidus, adult, donor10252	10161-103A8	72.50	10.25	2.44	0.49	0.49	0.49	1.71	27.34
globus pallidus, adult, donor10258	10367-105F7	24.65	8.22	0.00	0.00	0.00	0.00	2.74	13.69
globus pallidus, newborn, donor10223	10364-105F4	54.89	6.93	3.73	0.00	0.53	0.53	1.60	7.99
granulocyte macrophage progenitor, donor1	12131-128D7	122.36	26.92	2.45	0.00	0.00	4.89	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	5.23	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	31.04	5.12	0.00	0.00	0.64	0.64	0.00	8.32
hIPS +CCl2, biol_rep1	14383-156B9	41.78	8.26	0.46	0.00	1.84	0.46	0.00	15.15
hIPS +CCl2, biol_rep2	14384-156C1	27.44	3.20	0.46	0.00	1.37	0.46	0.91	14.18
hIPS +CCl2, biol_rep3	14385-156C2	31.56	4.51	0.00	0.00	0.64	0.00	0.00	19.32
hIPS, biol_rep1	14380-156B6	20.12	7.19	0.00	0.00	1.44	0.00	0.00	11.50
hIPS, biol_rep2	14381-156B7	19.89	6.17	2.06	0.00	0.00	0.00	1.37	20.58
hIPS, biol_rep3	14382-156B8	27.59	6.62	0.00	0.00	0.00	1.10	1.10	9.93
hairy cell leukemia cell line:Mo	10712-109I1	21.84	6.32	1.15	1.72	0.00	0.00	0.29	5.46
heart - mitral valve, adult	10205-103F7	58.60	6.88	3.89	1.20	0.90	0.60	0.00	18.24
heart - pulmonic valve, adult	10206-103F8	43.14	4.45	1.31	0.00	0.26	0.00	0.26	11.77
heart - tricuspid valve, adult	10207-103F9	96.59	9.99	9.16	3.33	2.50	0.83	1.67	20.82
heart, adult, diseased post-infarction, donor1	10050-101G5	40.81	4.49	0.41	0.00	1.02	0.61	0.41	6.53
heart, adult, diseased, donor1	10051-101G6	34.49	4.26	0.85	0.00	0.00	0.00	0.43	7.24
heart, adult, pool1	10016-101C7	47.15	2.99	0.23	0.46	0.69	0.46	0.00	28.98
heart, fetal, pool1	10046-101G1	71.36	7.60	2.05	0.41	0.62	1.54	1.03	15.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	46.28	2.78	1.23	1.85	0.31	0.62	0.31	20.36
hepatoblastoma cell line:HuH-6	10633-108I3	35.68	2.38	0.00	0.00	0.00	0.00	1.19	16.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.39	4.53	0.33	0.22	0.22	0.55	0.99	17.02
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	31.56	5.46	0.85	0.12	0.36	0.12	0.85	15.17
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	35.07	6.06	0.51	0.40	0.40	0.10	0.40	21.52
hepatoma cell line:Li-7	10484-107A7	47.82	5.45	0.22	0.11	0.44	0.89	0.00	24.47
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.94	4.32	0.00	0.00	0.10	1.11	0.60	6.43
hippocampus - adult, donor10196	10169-103B7	44.48	16.09	4.73	0.95	0.00	0.95	0.95	8.52
hippocampus, adult, donor10252	10153-102I9	53.07	9.80	1.43	0.41	0.61	0.82	0.41	13.47
hippocampus, adult, donor10258	10374-105G5	26.89	9.96	0.50	0.50	0.50	0.00	0.50	11.45
hippocampus, newborn, donor10223	10363-105F3	48.29	14.10	5.99	1.76	1.41	1.76	2.11	8.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	42.11	4.88	1.22	0.00	1.22	0.00	0.00	50.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	41.23	8.25	0.79	0.20	0.98	0.00	0.39	14.92
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	32.50	8.12	0.51	0.00	1.52	1.27	0.76	27.67
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	42.85	6.20	0.56	0.00	1.69	0.00	0.00	26.50
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.74	5.42	0.26	0.00	0.77	1.29	0.77	17.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	63.77	9.87	0.38	0.00	1.52	0.38	0.00	25.05
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	58.10	9.34	2.34	0.88	1.46	1.17	2.04	23.06
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	66.14	15.08	1.51	0.43	1.72	1.08	1.08	15.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	54.64	12.93	2.92	0.42	1.67	2.09	2.09	24.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	44.75	13.02	5.21	0.47	0.47	0.71	0.71	15.63
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.38	9.16	3.05	0.64	1.61	0.80	1.93	20.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.74	12.12	6.06	0.00	1.35	0.67	2.02	19.53
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.96	5.32	0.94	0.00	1.10	0.47	0.78	17.68
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	33.90	9.33	1.97	0.00	0.98	0.49	0.00	19.65
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	44.51	5.24	3.49	0.00	3.49	0.00	0.87	50.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	58.80	8.40	0.57	0.19	0.38	0.57	0.19	25.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	56.25	9.59	1.31	0.00	0.87	0.87	0.00	21.37
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	58.97	7.00	0.50	0.00	0.00	0.50	1.00	34.98
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	79.69	17.14	2.45	0.38	2.07	1.51	0.94	17.71
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	76.39	16.37	2.73	1.36	3.18	0.91	0.91	23.65
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	68.60	15.98	2.51	0.00	1.25	1.88	1.25	30.70
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	38.05	10.12	10.45	0.49	0.82	0.98	1.31	24.17
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.03	8.42	9.00	1.16	1.16	0.58	1.16	20.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	44.24	13.15	7.17	0.90	0.90	1.79	1.49	33.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.24	6.28	0.55	0.00	2.40	0.74	0.92	22.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	33.95	5.14	0.57	0.00	1.43	0.86	0.57	20.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	42.06	5.72	1.63	0.00	0.41	1.22	0.41	35.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.60	7.75	1.06	0.00	2.11	0.35	1.06	12.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	42.44	7.29	1.58	0.00	0.63	0.32	0.32	15.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	50.54	8.78	0.91	0.00	1.21	0.91	0.00	23.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	61.02	11.38	3.62	1.03	2.07	0.00	1.03	15.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	53.80	11.95	5.31	1.33	1.99	0.00	0.66	15.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	45.41	10.00	2.82	0.00	2.82	0.51	1.03	13.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.88	8.95	7.41	1.02	1.28	0.51	1.02	13.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	53.01	14.39	14.39	0.00	0.76	1.51	2.27	21.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	42.68	9.41	5.04	0.34	1.34	0.34	1.68	36.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	34.78	5.55	0.48	0.48	1.45	0.72	0.00	15.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	45.46	7.13	1.78	0.00	0.45	1.78	0.45	34.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	31.22	4.88	2.44	0.49	1.95	0.98	0.98	21.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	51.65	7.33	0.31	0.00	1.22	0.00	0.31	18.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	162.66	26.03	3.25	3.25	0.00	3.25	0.00	110.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	64.86	9.27	0.00	0.00	1.65	0.66	0.99	40.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	47.61	9.30	1.64	0.00	1.09	1.09	1.09	16.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	69.12	15.56	1.09	0.36	1.09	1.81	1.45	21.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	49.82	13.88	2.49	0.00	1.07	1.42	1.42	19.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	27.45	5.97	4.77	0.00	0.00	0.00	0.00	21.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	47.40	13.27	5.01	0.54	0.54	0.68	1.63	11.10
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.17	8.89	2.42	0.81	0.00	0.54	0.54	21.28
immature langerhans cells, donor1	11904-125F5	102.43	12.59	14.53	9.69	0.48	1.45	0.48	16.47
immature langerhans cells, donor2	11905-125F6	123.57	15.84	3.96	3.96	2.38	0.79	0.00	6.34
insula, adult, pool1	10039-101F3	70.41	15.80	2.18	2.84	0.09	2.18	1.70	8.33
keratoacanthoma cell line:HKA-1	10791-110H8	41.62	6.18	0.33	0.33	1.63	0.33	0.00	12.68
kidney, adult, pool1	10017-101C8	31.74	5.81	1.60	0.60	0.30	0.30	0.30	16.42
kidney, fetal, pool1	10045-101F9	51.92	9.20	0.50	0.57	0.00	1.13	0.99	5.09
large cell lung carcinoma cell line:IA-LM	10509-107D5	75.98	9.52	4.40	1.14	0.43	0.71	0.43	40.19
large cell lung carcinoma cell line:NCI-H460	10839-111E2	39.40	3.18	0.00	0.14	0.97	0.41	0.28	9.40
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	74.13	7.34	0.18	1.10	0.00	0.55	1.28	32.66
left atrium, adult, donor1	10079-102A7	25.61	2.18	0.54	0.00	0.54	0.00	0.00	8.72
left ventricle, adult, donor1	10078-102A6	36.41	2.53	0.51	1.01	0.51	0.00	0.51	5.06
leiomyoblastoma cell line:G-402	10721-110A1	24.35	4.38	0.82	0.00	0.00	0.00	0.00	9.58
leiomyoma cell line:10964C	10569-108B2	31.25	11.86	5.39	2.16	0.72	0.36	1.08	15.09
leiomyoma cell line:15242A	10570-108B3	43.48	8.70	2.72	0.54	0.00	0.54	0.00	20.11
leiomyoma cell line:15425	10571-108B4	58.28	9.96	5.34	5.58	1.21	0.49	0.73	22.58
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	0.00	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	42.87	5.23	0.00	0.00	0.00	0.00	1.05	7.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	48.88	8.26	1.06	1.53	0.35	1.18	0.12	13.93
liposarcoma cell line:KMLS-1	10782-110G8	52.17	9.37	2.81	2.19	0.47	0.62	0.31	12.50
liposarcoma cell line:SW 872	10726-110A6	22.54	1.71	0.00	0.00	0.00	0.12	0.37	11.21
liver, adult, pool1	10018-101C9	28.04	2.43	0.49	0.32	0.16	0.32	0.16	10.37
liver, fetal, pool1	10086-102B5	18.81	2.82	0.00	0.00	0.94	1.88	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	59.50	12.83	4.23	1.31	0.00	1.31	1.46	14.58
locus coeruleus, adult, donor10252	10165-103B3	52.78	9.41	2.21	1.66	0.74	0.74	0.92	18.64
locus coeruleus, adult, donor10258	10375-105G6	32.16	10.16	1.41	0.28	0.56	0.85	0.85	6.49
locus coeruleus, newborn, donor10223	10362-105F2	45.43	6.31	7.99	4.63	0.00	1.68	0.42	26.08
lung adenocarcinoma cell line:A549	10499-107C4	27.68	2.63	0.14	0.00	0.14	0.14	0.28	12.87
lung adenocarcinoma cell line:PC-14	10408-106B3	51.71	6.20	0.00	0.00	0.00	0.00	0.00	12.41
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.29	5.67	1.19	1.19	1.05	0.13	0.40	14.90
lung, adult, pool1	10019-101D1	72.88	8.39	4.25	0.95	0.59	0.71	0.47	15.47
lung, fetal, donor1	10068-101I5	114.16	19.41	9.42	0.86	1.14	0.57	1.14	33.68
lung, right lower lobe, adult, donor1	10075-102A3	36.66	5.04	4.12	1.37	0.92	0.46	0.92	9.16
lymph node, adult, donor1	10077-102A5	28.40	10.89	0.47	1.42	0.00	0.00	0.47	3.79
lymphangiectasia cell line:DS-1	10727-110A7	31.34	3.07	0.00	0.00	0.00	0.22	0.66	5.92
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	27.62	6.04	0.00	0.00	0.30	0.60	1.21	6.94
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	90.05	10.19	5.95	3.40	0.00	0.00	0.00	119.78
mature adipocyte, donor1	12231-129F8	55.50	7.99	1.33	0.44	0.00	0.00	0.00	11.10
mature adipocyte, donor2	12232-129F9	52.92	5.81	1.25	0.21	1.25	0.00	0.62	11.00
mature adipocyte, donor3	12233-129G1	52.15	7.59	3.08	1.19	0.24	2.13	0.71	13.04
mature adipocyte, donor4	12234-129G2	63.44	6.84	2.63	1.32	0.79	0.79	0.26	10.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	98.88	11.91	0.24	0.00	0.48	1.19	0.95	24.30
medial frontal gyrus - adult, donor10196	10170-103B8	56.40	18.05	0.00	4.51	0.00	0.00	3.38	15.79
medial frontal gyrus, adult, donor10252	10150-102I6	51.49	8.28	2.02	3.13	0.55	0.92	0.92	14.34
medial frontal gyrus, adult, donor10258	10368-105F8	32.72	8.26	0.00	0.95	0.32	1.59	1.59	12.39
medial frontal gyrus, newborn, donor10223	10352-105E1	47.77	8.10	19.62	6.82	0.85	1.28	1.71	8.96
medial temporal gyrus - adult, donor10196	10183-103D3	71.55	11.81	4.05	4.22	1.35	2.53	2.03	9.45
medial temporal gyrus, adult, donor10252	10156-103A3	59.42	8.28	2.97	2.12	0.85	0.42	0.42	14.43
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	11.56	0.00	1.93	0.00	0.00	0.00	13.48
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	14.35	0.00	28.71	0.00	0.00	0.00	114.83
medial temporal gyrus, newborn, donor10223	10353-105E2	43.07	14.00	9.33	3.23	0.36	1.08	0.72	7.54
medulla oblongata - adult, donor10196	10174-103C3	42.18	5.84	10.38	0.65	0.00	0.65	1.95	15.58
medulla oblongata, adult, donor10252	10155-103A2	52.32	6.50	2.01	1.55	0.31	0.77	0.46	14.71
medulla oblongata, adult, pool1	10038-101F2	58.20	10.94	2.20	0.73	0.08	1.22	0.90	7.92
medulla oblongata, newborn, donor10223	10361-105F1	42.70	6.60	6.60	2.08	1.04	0.35	0.35	13.19
medulloblastoma cell line:D283 Med	10838-111E1	35.65	6.20	0.00	0.00	0.00	0.66	0.44	7.31
medulloblastoma cell line:ONS-76	10759-110E3	30.45	5.75	0.49	0.12	0.00	0.98	0.61	7.58
melanoma cell line:COLO 679	10514-107E1	70.15	9.20	0.29	0.43	0.43	0.72	1.15	20.27
melanoma cell line:G-361	10465-106H6	35.83	3.26	0.00	0.54	1.09	0.27	0.54	11.94
meningioma cell line:HKBMM	10691-109F7	53.37	6.33	1.27	1.27	0.36	0.18	0.36	20.98
merkel cell carcinoma cell line:MKL-1	10843-111E6	50.23	7.93	0.00	0.88	0.88	0.00	0.00	19.39
merkel cell carcinoma cell line:MS-1	10844-111E7	25.14	4.93	0.00	0.00	0.00	0.78	0.52	9.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	44.80	7.98	2.76	2.15	0.31	0.61	0.31	12.58
mesenchymal precursor cell - adipose, donor2	11748-123G2	55.08	7.63	3.82	1.45	0.55	0.18	0.00	7.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	36.44	5.80	2.48	2.48	0.41	0.41	0.00	12.84
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	26.27	5.34	2.53	1.26	0.00	0.00	0.00	5.62
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	30.62	7.32	2.12	1.16	0.00	0.58	0.00	7.70
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	9.02	9.02	4.16	0.00	0.69	0.69	24.99
mesenchymal precursor cell - cardiac, donor1	11752-123G6	43.94	6.01	2.92	2.06	1.03	0.34	0.34	9.27
mesenchymal precursor cell - cardiac, donor2	11753-123G7	43.36	4.72	1.04	0.58	0.23	0.46	0.46	8.74
mesenchymal precursor cell - cardiac, donor3	11754-123G8	35.68	6.50	1.86	1.99	0.13	0.80	0.66	7.69
mesenchymal precursor cell - cardiac, donor4	11755-123G9	42.94	7.02	5.13	3.24	0.27	0.41	0.54	9.86
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	43.96	5.98	2.13	1.28	0.14	0.43	0.14	7.68
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.92	4.94	2.96	4.61	0.66	0.33	0.00	19.43
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	43.86	6.37	1.25	1.38	0.28	0.14	0.42	8.03
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	40.84	6.28	1.75	2.09	0.00	0.35	0.70	21.29
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	43.08	4.70	0.61	0.82	0.20	0.61	0.41	10.21
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	35.59	6.83	2.16	0.72	0.72	0.36	1.08	21.57
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	28.97	5.38	1.34	2.07	0.21	0.21	0.41	7.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	37.16	6.84	3.65	1.82	0.68	0.46	1.14	13.22
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.87	13.43	5.03	5.87	0.00	0.00	2.52	14.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	34.07	7.47	1.20	1.49	0.30	0.75	0.00	7.02
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	37.46	4.20	0.79	1.31	0.09	0.44	0.09	9.19
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	30.93	5.52	0.37	1.47	0.37	0.00	0.00	8.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	36.34	8.30	2.00	1.43	0.00	0.57	0.86	17.46
mesenchymal stem cell line:Hu5/E18	10568-108B1	36.21	8.00	0.84	1.26	0.42	0.84	0.42	29.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	34.71	7.76	4.11	4.57	0.00	0.91	0.00	8.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	40.16	10.49	6.14	0.77	0.26	0.00	0.00	22.76
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	48.42	7.59	4.45	0.79	0.26	0.79	0.26	17.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	48.68	9.55	4.93	0.92	0.00	1.23	0.00	15.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	40.95	11.53	4.71	0.00	0.24	0.00	0.24	20.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	41.29	10.49	6.43	1.69	0.00	0.00	0.34	15.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	44.01	10.22	5.11	0.79	0.00	0.79	0.00	20.43
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	38.46	12.05	3.71	1.39	0.46	0.46	0.00	21.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.88	8.94	5.77	1.73	0.00	0.29	0.29	13.27
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	43.73	10.93	2.68	0.89	1.12	1.12	0.67	15.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	42.30	7.93	3.85	0.48	0.24	0.48	0.96	12.50
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	68.20	8.80	4.40	2.93	0.00	1.47	1.47	16.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	41.62	9.73	2.69	0.67	0.67	1.01	1.01	14.77
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	39.30	14.33	5.32	0.82	0.00	2.05	0.82	14.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	49.83	8.59	6.44	1.72	0.43	1.72	1.29	15.03
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	54.69	13.67	0.00	0.00	2.73	0.00	0.00	24.61
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	0.00	5.16	5.16	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	48.39	8.77	4.87	2.60	0.97	1.30	0.32	24.03
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	53.83	18.91	8.73	2.91	0.00	1.45	1.45	33.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	48.51	12.79	3.73	3.20	2.13	1.07	0.53	15.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	49.07	11.45	2.45	0.00	0.00	0.00	0.00	22.90
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	45.09	8.94	5.05	0.78	1.17	0.00	0.39	14.38
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	2.10	8.39	2.10	0.00	0.00	0.00	16.79
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	47.69	8.94	2.98	1.99	0.00	0.00	0.99	20.86
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	4.77	0.00	4.77	0.00	0.00	0.00	19.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.62	7.12	5.34	1.19	0.59	0.59	1.78	25.50
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	51.18	13.40	4.87	0.00	2.44	1.22	0.00	15.84
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	50.04	10.77	5.70	1.90	1.90	0.63	0.63	25.97
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.70	6.21	4.14	3.79	0.69	0.34	0.00	12.42
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	42.98	2.15	4.30	6.45	0.00	0.00	0.00	15.04
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	3.99	0.00	0.00	0.00	0.00	35.93
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	3.44	0.00	3.44	0.00	0.00	0.00	13.78
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	29.34	6.11	4.48	3.26	0.00	0.81	0.41	18.34
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	37.34	4.77	3.18	1.59	0.00	0.00	0.00	11.12
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	29.48	2.36	2.36	2.95	0.00	0.59	0.00	20.63
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.94	3.74	4.99	3.43	0.00	0.31	0.31	19.33
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	1.34	4.01	5.35	0.00	0.00	0.00	22.72
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	33.11	10.64	3.55	3.55	1.18	2.37	0.00	10.64
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	2.57	2.57	0.00	0.00	0.00	0.00	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	39.93	3.44	6.20	1.38	0.00	0.69	0.00	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	31.17	1.48	1.48	0.99	0.00	0.00	0.49	14.84
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	23.55	2.24	1.12	0.00	0.00	2.24	0.00	17.94
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	28.62	1.91	0.00	0.00	0.64	0.00	0.64	17.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	2.42	0.00	0.00	0.40	0.40	0.00	13.30
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	6.54	0.00	0.00	0.00	0.00	0.00	21.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	0.00	1.27	0.00	2.53	0.00	1.27	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	35.81	4.86	1.21	1.21	1.82	0.00	0.00	8.50
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	4.52	0.00	4.52	0.00	0.00	0.00	22.59
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.07	4.12	1.65	0.00	0.00	0.82	0.82	21.42
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	37.30	2.98	3.37	1.39	0.20	0.60	0.40	12.10
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.66	4.87	3.57	0.97	0.32	0.00	0.65	18.50
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	33.61	3.06	4.07	0.00	1.02	0.00	0.00	17.32
mesodermal tumor cell line:HIRS-BM	10696-109G3	31.72	2.32	1.55	0.00	0.00	0.00	0.77	6.96
mesothelioma cell line:ACC-MESO-1	10493-107B7	112.21	12.05	0.24	0.24	0.24	0.47	0.94	50.56
mesothelioma cell line:ACC-MESO-4	10494-107B8	71.36	9.27	5.79	1.16	0.00	0.23	0.46	28.73
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	0.00	0.00	0.00	0.00	0.00	0.00	29.92
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	36.68	2.98	1.34	1.44	0.31	0.31	0.21	14.28
mesothelioma cell line:Mero-25	10850-111F4	41.53	6.81	1.59	1.82	0.91	0.45	1.13	14.30
mesothelioma cell line:Mero-41	10851-111F5	52.07	8.31	0.98	0.73	0.73	0.73	0.73	31.29
mesothelioma cell line:Mero-48a	10852-111F6	62.89	11.29	1.55	1.99	0.22	1.11	0.66	27.01
mesothelioma cell line:Mero-82	10853-111F7	68.33	9.46	1.84	1.05	0.53	0.26	0.79	28.12
mesothelioma cell line:Mero-83	10854-111F8	51.75	6.64	1.87	1.53	0.51	0.85	0.17	18.72
mesothelioma cell line:Mero-84	10855-111F9	37.92	7.08	0.25	0.00	1.01	0.76	0.25	13.65
mesothelioma cell line:Mero-95	10856-111G1	44.93	7.66	1.86	1.04	0.41	1.45	1.86	14.70
mesothelioma cell line:NCI-H2052	10847-111F1	67.09	10.10	2.98	1.99	0.50	0.99	0.33	27.00
mesothelioma cell line:NCI-H226	10846-111E9	43.08	4.34	1.27	0.18	0.18	0.18	0.36	23.71
mesothelioma cell line:NCI-H2452	10848-111F2	55.18	7.52	1.02	2.56	0.17	0.00	0.85	25.28
mesothelioma cell line:NCI-H28	10845-111E8	49.88	6.36	1.02	0.25	0.25	0.25	0.76	20.36
mesothelioma cell line:No36	10857-111G2	24.14	4.57	0.00	0.00	0.00	0.33	1.30	8.48
mesothelioma cell line:ONE58	10858-111G3	44.17	7.32	0.54	0.54	0.27	0.27	0.81	20.59
migratory langerhans cells, donor1	11901-125F2	34.93	6.14	0.96	0.77	0.38	0.58	0.58	5.76
migratory langerhans cells, donor2	11902-125F3	28.45	2.69	0.98	0.61	0.24	0.49	0.73	6.84
migratory langerhans cells, donor3	11903-125F4	37.69	3.95	1.26	1.26	0.36	0.72	0.72	10.59
mixed mullerian tumor cell line:HTMMT	10689-109F5	72.48	8.16	0.33	0.00	1.31	0.33	0.00	47.67
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.53	2.97	0.00	0.85	0.21	0.21	0.00	5.30
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	60.81	4.38	0.23	0.69	1.15	0.23	0.69	14.05
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	20.55	3.81	0.76	0.76	0.19	0.19	0.19	6.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	44.90	5.73	0.00	0.00	0.00	0.00	0.00	10.35
myeloma cell line:PCM6	10474-106I6	42.89	7.71	0.20	0.59	0.00	1.58	0.40	13.84
myxofibrosarcoma cell line:MFH-ino	10600-108E6	19.78	4.57	0.00	0.00	0.00	0.00	0.00	6.59
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.09	2.75	1.77	0.59	0.20	0.20	0.20	11.38
nasal epithelial cells, donor1, tech_rep1	12226-129F3	114.10	15.82	0.56	1.45	0.56	0.78	1.56	27.41
nasal epithelial cells, donor1, tech_rep2	12226-129F3	101.78	14.27	1.25	1.40	0.51	1.18	0.96	34.71
nasal epithelial cells, donor2	12227-129F4	93.84	12.14	1.66	1.66	0.55	1.66	1.10	11.59
neuroblastoma cell line:CHP-134	10508-107D4	46.24	5.75	1.15	0.00	0.23	0.23	0.69	35.43
neuroblastoma cell line:NB-1	10539-107G8	74.09	20.58	0.75	0.56	0.00	1.68	2.43	23.20
neuroblastoma cell line:NBsusSR	10607-108F4	27.20	3.37	0.21	0.00	0.21	0.21	0.21	13.92
neuroblastoma cell line:NH-12	10555-107I6	49.38	7.64	0.19	0.00	1.12	0.37	0.75	24.41
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	41.51	6.17	0.24	0.00	0.24	0.24	0.24	9.49
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	51.00	10.61	3.17	0.16	0.48	0.95	0.32	16.79
neuroectodermal tumor cell line:TASK1	10774-110F9	23.14	5.03	0.00	0.00	0.20	0.40	0.60	8.25
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	5.09	0.00	0.64	0.00	1.27	0.00	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	35.93	4.26	1.60	0.27	0.53	1.06	0.00	25.55
neutrophil PMN, donor1	12133-128D9	29.75	29.75	0.00	0.00	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28	0.00	0.00	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	37.88	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	61.56	7.27	0.00	0.00	0.85	0.51	0.51	17.76
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	29.62	6.40	2.40	0.00	0.00	0.80	0.00	6.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.68	8.34	2.89	0.32	1.28	0.32	0.96	14.11
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	48.61	8.41	2.36	0.00	0.53	0.53	0.00	29.69
nucleus accumbens, adult, pool1	10037-101F1	60.56	13.40	1.41	1.78	0.19	1.31	1.59	8.62
occipital cortex - adult, donor10196	10172-103C1	53.57	10.30	0.00	4.12	0.00	0.00	2.06	6.18
occipital cortex, adult, donor10252	10163-103B1	59.84	7.51	2.68	1.88	0.27	0.54	1.34	20.40
occipital cortex, newborn, donor10223	10355-105E4	51.32	16.01	6.55	3.28	1.46	1.46	1.09	8.73
occipital lobe, adult, donor1	10076-102A4	60.35	15.74	1.05	1.05	0.52	2.10	0.79	15.74
occipital lobe, fetal, donor1	10073-102A1	110.71	30.90	6.87	2.15	2.57	3.86	3.43	11.59
occipital pole, adult, pool1	10036-101E9	41.63	10.49	0.47	1.18	0.08	1.66	1.42	4.18
olfactory region, adult	10195-103E6	45.28	8.41	1.34	2.48	0.57	1.34	0.57	8.02
optic nerve, donor1	10277-104E7	70.04	14.01	2.00	4.00	4.00	0.00	0.00	20.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	65.50	9.57	0.91	0.57	0.34	0.57	1.03	25.52
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	36.27	6.05	0.00	0.00	0.00	0.14	0.27	12.64
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	76.70	9.99	1.86	1.02	1.19	0.00	0.17	32.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	52.67	8.20	0.12	0.35	0.58	0.46	0.12	26.80
osteoclastoma cell line:Hs 706.T	10704-109H2	39.10	5.59	0.59	1.47	0.29	0.29	0.59	15.58
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	52.32	2.80	1.87	0.93	0.00	0.00	0.00	27.10
osteosarcoma cell line:HS-Os-1	10558-107I9	24.39	4.03	0.85	0.42	0.00	0.00	0.21	6.15
ovary, adult, pool1	10020-101D2	49.09	7.08	0.79	1.22	0.26	0.61	0.61	7.25
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.85	4.22	0.37	0.73	0.00	0.73	0.18	18.70
pancreas, adult, donor1	10049-101G4	22.58	5.64	0.00	0.94	0.94	0.94	0.00	13.17
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.03	3.35	0.00	0.56	0.00	0.56	0.00	15.09
papillary adenocarcinoma cell line:8505C	10437-106E5	65.25	4.26	1.87	0.85	0.68	0.51	0.34	29.13
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	40.40	5.30	1.82	1.16	0.17	0.17	0.83	16.39
paracentral gyrus, adult, pool1	10035-101E8	58.12	15.10	1.10	2.93	0.37	1.19	1.46	8.69
parietal cortex, adult, donor10258	10373-105G4	41.10	12.48	2.94	0.73	0.00	0.73	1.47	9.54
parietal lobe - adult, donor10196	10171-103B9	51.73	10.35	0.94	2.82	0.00	0.94	0.00	6.58
parietal lobe, adult, donor10252	10157-103A4	52.45	9.98	3.42	3.42	0.86	0.29	1.14	17.10
parietal lobe, adult, pool1	10034-101E7	58.60	13.57	0.88	1.67	0.09	1.15	0.88	6.96
parietal lobe, fetal, donor1	10072-101I9	79.53	16.49	7.76	4.85	0.97	0.97	0.97	22.31
parietal lobe, newborn, donor10223	10356-105E5	55.33	12.71	11.96	2.62	0.75	0.37	2.62	9.72
parotid gland, adult	10199-103F1	37.00	2.47	0.00	0.00	0.62	0.00	0.62	17.88
penis, adult	10200-103F2	49.95	4.83	1.07	0.54	0.54	1.61	0.54	22.02
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	57.27	5.21	0.19	0.00	0.37	0.00	0.19	13.57
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	57.40	6.26	0.15	0.15	0.44	1.31	0.00	27.97
pineal gland - adult, donor10196	10179-103C8	47.73	6.45	1.94	0.00	1.29	1.29	0.00	16.77
pineal gland, adult, donor10252	10160-103A7	63.37	8.88	2.37	0.59	0.59	0.59	0.59	17.17
pineal gland, adult, donor10258	10377-105G8	42.64	5.64	0.63	0.63	0.63	0.00	0.63	16.30
pituitary gland - adult, donor10196	10180-103C9	70.83	10.12	13.15	5.06	2.02	2.02	1.01	17.20
pituitary gland, adult, donor10252	10162-103A9	91.73	11.99	7.82	6.25	1.04	0.52	2.08	22.93
pituitary gland, adult, donor10258	10378-105G9	49.37	9.36	4.26	2.55	2.55	0.00	4.26	17.88
placenta, adult, pool1	10021-101D3	43.22	5.81	0.54	0.32	0.65	0.65	0.75	12.26
plasma cell leukemia cell line:ARH-77	10840-111E3	34.43	5.43	0.00	0.00	0.13	0.66	0.53	7.28
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	40.15	5.60	0.16	0.93	0.16	0.31	0.47	12.45
pons, adult, pool1	10033-101E6	59.39	15.32	2.41	0.69	0.26	1.72	1.46	10.76
postcentral gyrus, adult, pool1	10032-101E5	52.74	10.37	1.22	2.88	0.26	1.39	1.74	7.85
promyelocytes/myelocytes PMC, donor1	12132-128D8	66.92	20.91	0.00	2.09	0.00	2.09	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	70.65	9.47	1.17	0.87	0.29	0.87	0.58	24.47
prostate cancer cell line:PC-3	10439-106E7	109.81	14.16	0.36	0.36	0.00	0.91	0.91	53.54
prostate, adult, pool1	10022-101D4	51.15	8.89	1.45	0.63	0.82	1.45	0.82	11.97
putamen, adult, donor10196	10176-103C5	66.33	13.46	3.07	4.49	0.24	0.71	0.71	12.51
putamen, adult, donor10252	10152-102I8	56.86	3.92	0.00	3.92	0.00	0.00	0.00	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	3.28	3.28	2.19	0.00	0.00	0.00	15.30
putamen, adult, donor10258, tech_rep2	10372-105G3	40.83	7.73	1.93	1.45	0.48	1.21	0.97	10.39
putamen, newborn, donor10223	10365-105F5	68.97	7.50	19.49	3.00	0.75	0.00	1.50	26.99
rectal cancer cell line:TT1TKB	10469-106I1	28.22	2.91	0.29	0.29	0.00	0.29	0.29	9.60
rectum, fetal, donor1	10067-101I4	38.95	11.13	0.00	1.39	0.00	2.78	0.00	19.47
renal cell carcinoma cell line:OS-RC-2	10411-106B6	39.22	6.78	0.21	0.21	0.00	0.21	0.21	9.54
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	72.90	9.94	0.41	1.24	0.00	0.41	0.83	21.54
retina, adult, pool1	10030-101E3	52.78	5.96	2.09	0.80	0.10	0.99	0.80	7.75
retinoblastoma cell line:Y79	10475-106I7	27.02	5.46	0.00	0.00	0.26	0.78	0.52	12.21
rhabdomyosarcoma cell line:KYM-1	10787-110H4	33.69	7.75	0.12	0.00	0.12	0.25	0.37	14.88
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	29.24	5.34	0.00	0.00	0.56	0.00	0.28	17.43
sacrococcigeal teratoma cell line:HTST	10695-109G2	65.93	5.30	0.76	0.00	2.27	0.00	0.00	9.85
salivary acinar cells, donor1	11771-123I7	67.49	10.52	2.10	1.46	0.65	0.16	0.49	13.27
salivary acinar cells, donor2	11772-123I8	65.81	10.19	2.20	0.96	0.96	0.28	0.41	10.74
salivary acinar cells, donor3	11773-123I9	52.96	6.62	0.66	0.00	0.66	0.00	0.66	9.93
salivary gland, adult, pool1	10093-102C3	43.47	7.44	0.00	0.00	0.57	0.00	0.00	15.44
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	91.65	10.79	4.55	5.40	1.01	0.84	0.67	33.64
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	82.52	8.93	5.52	6.11	0.35	0.71	0.47	25.16
seminal vesicle, adult	10201-103F3	61.37	12.17	2.12	1.06	3.70	0.00	1.06	29.63
serous adenocarcinoma cell line:JHOS-2	10639-108I9	63.89	9.47	1.94	0.73	0.97	0.73	0.24	18.22
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	38.00	6.54	1.76	0.25	0.75	0.50	1.01	12.58
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	38.13	16.06	3.01	0.00	0.00	0.00	3.01	34.12
serous cystadenocarcinoma cell line:HTOA	10693-109F9	52.79	9.27	6.04	0.54	0.40	0.94	0.27	24.31
signet ring carcinoma cell line:Kato III	10436-106E4	78.03	10.50	0.00	0.33	0.44	0.55	0.22	29.07
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.09	4.52	0.52	0.90	0.00	0.13	0.26	22.45
skeletal muscle - soleus muscle, donor1	10282-104F3	51.78	9.22	1.42	0.00	0.00	0.00	0.00	12.06
skeletal muscle, adult, pool1	10023-101D5	49.05	3.48	0.48	0.36	0.72	0.36	0.84	16.79
skeletal muscle, fetal, donor1	10066-101I3	17.09	2.01	0.00	1.01	0.00	0.00	0.00	3.02
skin, adult, donor1	10074-102A2	40.71	0.00	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	87.74	10.73	3.79	0.00	1.89	1.26	0.00	23.36
small cell cervical cancer cell line:HCSC-1	10800-110I8	39.69	9.67	1.33	0.00	0.00	0.67	0.00	16.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	29.31	4.73	0.32	0.00	0.63	0.00	0.32	10.09
small cell lung carcinoma cell line:DMS 144	10841-111E4	62.06	10.41	0.19	0.00	0.19	1.35	0.39	12.14
small cell lung carcinoma cell line:LK-2	10541-107H1	79.28	12.53	0.82	0.00	0.00	0.66	0.66	28.68
small cell lung carcinoma cell line:NCI-H82	10842-111E5	41.98	8.20	0.00	0.00	0.16	0.32	0.48	5.95
small cell lung carcinoma cell line:WA-hT	10562-108A4	34.00	3.70	0.44	1.31	0.44	0.00	0.44	27.02
small intestine, adult, pool1	10024-101D6	64.50	8.84	1.19	0.72	0.48	1.43	0.48	28.43
small intestine, fetal, donor1	10064-101I1	39.07	7.13	1.23	0.49	0.25	1.23	1.47	8.60
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	39.49	6.15	0.00	0.51	0.00	0.00	1.03	22.05
smooth muscle, adult, pool1	10048-101G3	66.16	6.46	2.07	0.78	0.52	0.52	0.52	8.27
somatostatinoma cell line:QGP-1	10781-110G7	60.57	7.77	1.07	1.34	0.54	1.34	1.34	13.13
spinal cord - adult, donor10196	10181-103D1	62.40	8.49	5.74	2.06	0.69	1.38	0.69	7.34
spinal cord, adult, donor10252	10159-103A6	67.42	6.70	3.55	2.37	0.39	0.00	1.18	11.83
spinal cord, adult, donor10258	10369-105F9	26.29	4.15	3.46	1.38	0.00	0.00	0.69	19.37
spinal cord, fetal, donor1	10056-101H2	60.98	12.81	1.83	2.44	1.22	3.66	3.05	15.86
spinal cord, newborn, donor10223	10359-105E8	48.22	5.05	5.97	0.92	0.46	0.00	0.92	18.37
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	53.32	10.90	3.29	1.79	0.30	0.75	0.30	20.16
spleen, adult, pool1	10025-101D7	37.01	4.41	0.55	0.77	0.33	0.77	0.44	13.99
spleen, fetal, pool1	10044-101F8	56.49	9.38	1.03	1.03	0.16	1.27	0.87	4.77
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	30.95	4.24	0.41	0.21	0.21	0.52	0.62	10.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	93.23	12.15	0.57	0.57	0.95	0.76	0.95	38.35
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.72	9.09	0.00	0.35	1.05	0.70	0.00	21.67
squamous cell carcinoma cell line:T3M-5	10616-108G4	125.88	12.51	2.35	2.74	1.17	0.78	0.39	32.45
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	63.37	14.75	2.81	4.16	0.56	1.13	1.13	38.27
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.76	3.39	0.00	0.00	0.42	0.00	0.00	6.35
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.92	0.85	0.42	0.42	0.00	0.42	0.00	9.73
stomach, fetal, donor1	10062-101H8	58.74	9.61	2.14	0.00	0.00	0.00	0.00	16.02
submaxillary gland, adult	10202-103F4	42.16	5.70	0.57	0.00	0.00	0.57	1.71	9.68
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00	0.00	814.11
substantia nigra, adult, donor10252	10158-103A5	60.44	5.61	0.83	0.62	0.00	0.62	0.21	19.73
substantia nigra, adult, donor10258	10371-105G2	20.69	5.69	1.55	0.00	1.03	0.00	1.03	14.48
substantia nigra, newborn, donor10223	10358-105E7	40.98	3.53	3.53	0.71	0.00	0.71	0.71	22.61
synovial sarcoma cell line:HS-SY-II	10441-106E9	62.59	11.46	0.46	0.23	0.69	1.15	2.52	22.24
temporal lobe, adult, pool1	10031-101E4	42.39	11.36	0.85	0.85	0.25	0.93	1.19	4.15
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.83	13.53	1.42	1.42	0.71	4.27	2.14	7.12
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	57.58	13.19	1.76	2.20	0.88	1.32	2.64	27.25
tenocyte, donor1	11763-123H8	38.40	4.89	5.24	1.75	0.00	0.70	0.00	22.69
tenocyte, donor2	11765-123I1	36.24	7.63	5.34	1.91	0.00	0.38	0.38	21.36
tenocyte, donor3	11768-123I4	40.40	8.90	5.56	0.74	0.00	0.74	0.00	24.83
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	50.14	6.97	2.04	0.51	1.02	0.85	1.53	28.89
teratocarcinoma cell line:NCR-G1	10798-110I6	24.51	3.24	0.00	0.00	0.31	0.92	0.00	7.86
teratocarcinoma cell line:PA-1	10807-111A6	31.31	4.65	0.15	0.15	0.15	0.62	0.31	12.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	42.02	9.90	1.40	0.00	0.89	1.27	0.63	11.81
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	34.41	10.97	0.76	0.00	0.76	1.51	0.76	21.93
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	70.56	17.45	1.31	0.22	0.65	1.74	1.53	11.56
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	46.25	13.35	0.00	0.33	0.65	0.65	1.63	14.98
testis, adult, pool1	10026-101D8	62.71	7.19	0.64	0.86	0.54	0.86	0.86	11.60
testis, adult, pool2	10096-102C6	76.68	11.28	0.00	0.00	2.26	0.45	0.90	15.34
thalamus - adult, donor10196	10168-103B6	64.03	11.04	1.10	1.10	0.00	1.10	0.00	25.39
thalamus, adult, donor10252	10154-103A1	52.67	6.88	0.94	0.94	0.63	0.16	0.47	19.54
thalamus, adult, donor10258, tech_rep1	10370-105G1	44.65	10.78	1.54	1.54	1.54	0.00	0.00	15.40
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.34	5.60	0.99	0.33	0.33	0.82	0.99	9.06
thalamus, newborn, donor10223	10366-105F6	29.92	10.36	9.21	0.58	0.00	0.00	1.15	15.53
throat, adult	10209-103G2	62.17	10.24	0.00	0.75	0.75	0.50	0.25	11.48
throat, fetal, donor1	10061-101H7	35.04	8.23	1.52	0.61	0.61	0.30	1.22	7.62
thymic carcinoma cell line:Ty-82	10803-111A2	51.87	7.95	0.20	0.20	0.20	0.79	0.99	13.32
thymus, adult, pool1	10027-101D9	61.24	13.92	1.09	0.70	0.30	1.59	1.89	7.75
thymus, fetal, pool1	10043-101F7	86.24	17.04	0.73	0.73	0.31	1.77	1.14	9.87
thyroid carcinoma cell line:KHM-5M	10776-110G2	57.70	6.52	0.93	1.99	0.80	0.66	0.53	18.35
thyroid carcinoma cell line:TCO-1	10783-110G9	81.30	12.01	0.70	1.40	0.28	1.54	1.68	35.62
thyroid, adult, pool1	10028-101E1	42.64	6.25	4.01	1.96	0.09	0.84	0.65	12.13
thyroid, fetal, donor1	10060-101H6	41.92	8.17	5.80	0.26	0.79	0.26	0.53	9.76
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	15.40	6.16	3.08	3.08	0.00	3.08	15.40
tongue, adult	10203-103F5	71.40	13.49	1.40	0.47	2.33	0.47	1.16	11.63
tongue, fetal, donor1	10059-101H5	44.14	4.73	0.39	1.18	0.79	0.79	0.39	14.19
tonsil, adult, pool1	10047-101G2	75.73	17.03	0.80	0.30	0.20	1.80	1.80	10.02
trachea, adult, pool1	10029-101E2	62.66	9.73	2.45	1.15	0.41	0.98	1.31	19.63
trachea, fetal, donor1	10058-101H4	45.39	7.31	2.69	1.54	1.54	0.38	0.00	15.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	46.76	9.92	2.48	1.77	0.71	0.71	0.00	21.61
transitional-cell carcinoma cell line:5637	10418-106C4	53.50	8.81	1.62	1.11	0.71	0.81	0.61	18.34
transitional-cell carcinoma cell line:JMSU1	10492-107B6	62.83	5.80	0.47	0.78	0.47	0.94	0.78	16.77
tridermal teratoma cell line:HGRT	10694-109G1	36.15	9.51	1.90	1.90	1.90	0.00	0.00	19.03
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	44.02	5.08	0.85	1.02	0.25	0.51	0.42	13.63
umbilical cord, fetal, donor1	10057-101H3	33.38	4.17	4.17	0.00	0.00	0.00	0.00	14.61
uterus, adult, pool1	10100-102D1	68.93	13.14	2.22	0.68	0.34	0.34	1.19	13.14
uterus, fetal, donor1	10055-101H1	68.09	11.77	3.07	0.00	3.07	1.02	2.05	13.31
vagina, adult	10204-103F6	52.34	5.17	0.65	1.29	0.65	1.29	0.65	8.40
vein, adult	10191-103E2	43.18	8.55	1.10	0.44	1.10	0.22	0.44	10.74
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.97	4.54	0.00	0.00	0.27	0.00	0.27	6.14